Hematology

journal

Hematology is …
instance of (P31):
academic journalQ737498
open-access journalQ773668
scientific journalQ5633421

External links are
P6981ACNP journal ID71801
1068976
2974777
P8375Crossref journal ID75722
299757
P1250Danish Bibliometric Research Indicator (BFI) SNO/CNO5045
P5115Directory of Open Access Journals ID1024-5332
1607-8454
P1058ERA Journal ID16190
P236ISSN0882-8083
1024-5332
1607-8454
P1277JUFO ID56980
P1055NLM Unique ID9708388
P10283OpenAlex IDV195061619
P3181OpenCitations bibliographic resource ID64538
P7662Scilit journal ID1258330
P1156Scopus source ID24995
95427

P1240Danish Bibliometric Research Indicator level1
P8875indexed in bibliographic reviewScopusQ371467
Science Citation Index ExpandedQ104047209
P123publisherTaylor & FrancisQ880582
Maney PublishingQ6748462
P1476titleHematology

Reverse relations

published in (P1433)
Q47404801"Pawn Ball Megakaryocytes": from the marvellous medici and dear Old Saint Nick to the unsanctified marrow of myelodysplasia
Q39672189'Real-life' study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis.
Q50483826'Reflex' HPLC testing as a screening modality for variant hemoglobins: a pilot study of 1310 cases at a pediatric referral hospital.
Q464263262'-Chlorodeoxyadenosine Effectively Induces Complete Remission in Hairy Cell Leukaemia
Q878990996-Mercaptopurine, Still Valuable for the Palliative Treatment of Acute Myeloid Leukaemia
Q40494563A 45-year-old male with fever and hepatosplenomegaly
Q34545640A 5-year-old boy with hepatosplenomegaly
Q46009562A BCNU-containing Regimen, Mini-BEAM, with GM-CSF is a Safe and Effective Mobilizing Regimen Pre-stem Cell Transplantation in Lymphoma Patients.
Q33433875A Case of Childhood Anemia Complicated by a Red Cell Membrane Sugar Chain Anomaly with Low Levels of Sialic Acid
Q87876101A Case of Malignant Histiocytosis having Polyploid Clones Characterized by an Isochromosome of the Long Arm of Chromosome 17 [i(17q)] and t(9;22) Translocation
Q47684195A Case of Minimally Differentiated Acute Leukemia (AML-M0) Complicated by Ventricle Thrombosis During Remission-induction
Q87876099A Further Study on the Incidence of Nucleoli in Myeloblasts of Patients Suffering from Acute Myeloid Leukemia
Q87876105A Long-term Remission of a Recurrent Acute Lymphoblastic Leukaemia with Donor Leukocyte Infusions after Allogeneic Peripheral Blood Stem Cell Transplantation
Q87911021A Low CD34+ Cell Dose Predicts Relapse and Death Early following Autologous Blood Stem Cell Transplantation
Q83903835A Mexican way to cope with stem cell grafting
Q36269948A broad and integrated diagnostic work-up for a modern management of Acute Lymphoblastic Leukemia (ALL).
Q50174928A case of congenital dyserythropoietic anemia type II, Gilbert's syndrome and malleolar trophic ulcers.
Q48226483A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype
Q51009837A clinical analysis of primary testicular diffuse large B-cell lymphoma in China.
Q57655179A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death
Q50697610A comparison of conventional tube test and gel technique in evaluation of direct antiglobulin test.
Q39369214A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major
Q83926734A complication of steroid therapy in acute leukaemia--a case report
Q33436173A fatal case of transplantation-mediated alloimmune thrombocytopenia following liver transplantation
Q106647121A five-year retrospective study of treatment outcomes using the L-asparaginase-based regimen as a first-line chemotherapy protocol for patients diagnosed with extranodal NK/T-cell lymphoma, nasal-type, in Thailand
Q38442230A genetic features and gene interaction study for identifying the genes that cause hereditary spherocytosis
Q46924606A killer revealed: 10-year experience with beta-thalassemia intermedia
Q39174017A microplate reader-based method to quantify NADH-cytochrome b5 reductase activity for diagnosis of recessive congenital methaemoglobinemia
Q96021545A multicentre retrospective study of primary breast diffuse large B-cell and high-grade B-cell lymphoma treatment strategies and survival
Q86542140A mutational and expressional analysis of DNMT3A in acute myeloid leukemia cytogenetic subgroups
Q35670980A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria
Q98512655A novel EPB41 p.Trp704* mutation in a Korean patient with hereditary elliptocytosis: a case report
Q89855111A novel compound heterozygous mutation in DGKE in a Chinese patient causes atypical hemolytic uremic syndrome
Q83063399A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis
Q104470383A novel homozygous missense mutation (Met527Ile) in a consanguineous marriage family with inherited factor XII deficiency
Q102064426A novel β-thalassemia variant at HBB:c.14delC (Codon 4, -C) identified via next-generation sequencing
Q39337522A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia--a possible new therapeutic target.
Q49549984A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia.
Q40473999A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia.
Q46979566A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma.
Q42199323A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
Q42467301A prospective study of the hypothalamic-pituitary-adrenal axis in children with acute lymphoblastic leukemia receiving chemotherapy.
Q53550692A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms.
Q39156320A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation
Q33386717A retrospective analysis of therapeutic responses to two distinct corticosteroids in 259 children with acute primary idiopathic thrombocytopenic purpura
Q39045544A retrospective study of leukemia epidemiology in Northern Tunisia
Q36194538A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation
Q35670977A review of the molecular diagnosis of thalassemia
Q39135249A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience
Q85941673A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: The E-SAAN score
Q36194591A role for niches in hematopoietic cell development
Q45850500A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies
Q53543239A short note on the nuclear diameter in human early granulocytic progenitors.
Q43014789A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule
Q92329963A sporadic MYH9-related disease in a Chinese boy with p.A95T mutation
Q47374546A structure-function analysis in patients with prekallikrein deficiency.
Q46151236A study for evaluation of different diagnostic approaches in acute leukemia in Egypt
Q80376717A summary on the immunophenotyping of acute lymphoblastic leukemia in Thailand
Q90463316A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia
Q92910694A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia 1
Q90775885A triplex probe-based TaqMan qPCR assay for Calreticulin type I and II mutation detection
Q45918795ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
Q57457471ADAMTS-13 activity reduction in plasma of acute myeloid leukemia predicts poor prognosis after bone marrow transplantation
Q51099496ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia.
Q54333318AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients.
Q36194560AHSP and beta-thalassemia: a possible genetic modifier
Q39743670Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders
Q81203951Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells
Q46417608Aberration of p73 promoter methylation in de novo myelodysplastic syndrome
Q33403318Abnormal WBC scattergram: a clue to the diagnosis of malaria
Q33382851Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria.
Q92590626Abnormalities of quantities and functions of CD56bright natural killer cells in non-severe aplastic Anemia
Q38896394Abnormalities of the p53 Tumour Suppressor Gene in Mature B-cell Neoplasms
Q92727044Abstracts for issue YHEM 21 : S1
Q46984091Acquired Aplasia of the Bone Marrow
Q36328387Acquired coagulation inhibitor-associated bleeding disorders: an update
Q46411395Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency
Q36307579Acquired haemoglobin H disease
Q36497382Acquired hemophilia A.
Q36356147Acquired hemophilia A: a review of recent data and new therapeutic options
Q36194596Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure
Q84559367Acquired von Willebrand syndrome in multiple myeloma
Q87878034Activated Cellular Immunity in Chronic Hepatitis C
Q48910385Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
Q87876324Acute Colonic Graft-versus-host Disease and Ulcerative Colitis with Respect to Cytokines
Q87879361Acute Lymphoblastic Leukemia Occurring in a Case of Chronic Lymphocytic Leukemia
Q47618487Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice.
Q87911774Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969-1999
Q38896517Acute Myocardial Infarction in Sickle Cell Disease: Case Report and Review of the Literature
Q38894046Acute Normovolemic Hemodilution in Surgery
Q87924331Acute Promyelocytic Leukemia in Late Pregnancy. Successful Treatment with All-Trans-Retinoic Acid (ATRA) and Chemotherapy
Q41415693Acute leukemia in adults: novel allogeneic transplant strategies
Q35809438Acute leukemia subclassification: a marker protein expression perspective
Q46830755Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.
Q86035795Acute myeloid leukaemia
Q89077060Acute myeloid leukemia carrying ETV6 mutations: biologic and clinical features
Q41439053Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3.
Q44219898Acute physiological responses to physiotherapy applications pre and post autologous stem cell transplantation: an experimental study
Q35127005Acute promyelocytic leukemia: a case-based review.
Q36270144Acute promyelocytic leukemia: a model of molecular target based therapy.
Q43910279Acute respiratory distress syndrome in patients with hematological malignancies
Q45866634Adherence to clotting factors among persons with hemophilia A or B.
Q87875750Adhesion and Transendothelial Migration of Human Monocytes: Role of Cytokine (IL3, GM-CSF) Activated Endothelial Cells
Q42496327Adhesion of B-Cell Chronic Lymphocytic Leukemia Cells to Marrow Stromal Cells is Mediated by α4β1 but not β2αL Integrin: MSC also Prevent Apoptosis of B-CLL Cells
Q41073905Adhesion of Hematopoietic Precursors to Human Stroma: Studies Using Normal Marrow Stromal Myofibroblasts and a Stromal Cell Line Transformed by SV40.
Q84917056Adipogenic differentiation alters the immunoregulatory property of mesenchymal stem cells through BAFF secretion
Q87912677Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease
Q91628712Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement
Q50025361Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era.
Q34875170Adoptive cellular therapy: a therapeutic reality?
Q55240614Adult T-Cell Leukaemia-Lymphoma Relapsing as Hodgkin Disease Nodular Sclerosis Subtype.
Q83903727Adult T-cell leukemia-lymphoma
Q33358032Adult idiopathic thrombocytopenic purpura
Q33433923Advances in Platelet Counting
Q36687984Advances in the diagnosis and management of von Willebrand disease
Q33435590Advances in the pathophysiology of primary immune thrombocytopenia
Q91892793Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma
Q46830757Agnogenic myeloid metaplasia with pulmonary hematopoiesis
Q40122089All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication
Q39471124Allelic polymorphisms of human platelets-specific alloantigens in South Tunisian population.
Q38080144Alloantibodies in previously untreated hemophilia A patients: the role of environmental factors
Q38226100Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
Q40766061Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO).
Q83903710Allogeneic transplantation for aplastic anemia
Q36269924Allogeneic transplantation for chronic myelogenous leukemia
Q50574601Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin.
Q35008715Alpha globin gene numbers: an important modifier of HbE/beta thalassemia
Q58907737Alpha thalassemia gene mutations in neonates from Mazandaran, Iran, 2012
Q44935678Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity
Q37293525Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases
Q42631438Alterations of hemostasis after laparoscopic and open surgery
Q33407813Alternate considerations for current concepts in ITP.
Q39974781Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma
Q54200188Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms.
Q28274310Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma
Q80205154Amyloidosis: a changing clinical perspective
Q104682097An aberrant F8 intron 1 inversion with concomitant large duplication and deletion in a Chinese severe hemophilia A patient
Q54423844An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene.
Q53092886An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort.
Q45402341An unusual case of autoimmune hemolytic anemia in treatment naïve hepatitis C virus infection
Q37791615An update on disordered iron metabolism and iron overload
Q28307195Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists
Q47776224Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases
Q42288604Analysis of clinical characteristics of 516 patients with non-Hodgkin's lymphoma in Shanghai area
Q88289712Analysis of erythrocyte membrane proteins in patients with hereditary spherocytosis and other types of haemolytic anaemia
Q104749502Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment
Q91964192Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia
Q36069486Analysis of hemochromatosis gene mutations in 52 consecutive patients with polycythemia vera
Q91538778Analysis of long non-coding RNA expression in hemophilia A patients
Q98154390Analysis of rare thalassemia caused by HS-40 regulatory site deletion
Q80559469Anemia and hemoglobinopathies in tribal population of Eastern and North-eastern India
Q37737810Anemia and transfusions in geriatric patients: a time for evaluation
Q92157281Anemia in centenarians: prevalence and association with kidney function
Q38199176Anemia in malignancies: pathogenetic and diagnostic considerations.
Q38160129Angiogenesis and acute myeloid leukemia
Q36194525Angiogenesis and hematological malignancies
Q46377195Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia.
Q36069477Angiogenic switch in multiple myeloma.
Q44803743Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features
Q87341345Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia
Q58134838Announcement - Foro Latino Americano
Q58134835Announcement - Young Investigator Awards
Q48097208Anthropometric measurements in children having transfusion-dependent beta thalassemia.
Q36307590Anti HCV seroprevalence among the voluntary blood donors in Thailand
Q33433889Anti-Hepatitis C Virus Serology in Immune Thrombocytopenia: A Retrospective Analysis in 101 Patients
Q85680371Anti-carbonic anhydrase antibodies in iron deficiency anemia
Q38342043Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis
Q50047415Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis.
Q33433833Antiphospholipid Antibodies and Associated Clinical Manifestations
Q46830752Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia
Q81271157Antiphospholipid antibody syndrome
Q33386712Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection
Q38362937Antisense Oligonucleotides: Considerations for Lymphoma Therapy
Q87052921Aplastic anaemia
Q87189127Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major
Q36194530Apoptosis and immaturity in acute myeloid leukemia
Q53528286Apoptosis and proliferation differences between CD34+ and CD34- leukemic subpopulations in childhood acute leukemia.
Q81243501Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea
Q74000800Application of Resistance Reversal Agents in Hematologic Malignancies; Malignancy; Current Clinical Practice
Q50711111Application of flow cytometry in detection of red-cell-bound IgG in Coombs-negative AIHA.
Q35126995Application of the Molecular Analysis of the T-Cell Receptor Repertoire in the Study of Immune-Mediated Hematologic Diseases
Q50574603Are serum nitric oxide and vascular endothelial growth factor levels affected by packed red blood cell transfusions?
Q33433827Are there "Attenuated" Forms of Evans Syndrome?
Q45204114Arginine supplementation improves rotorod performance in sickle transgenic mice
Q39066853Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines
Q40001380Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study
Q36194579Arsenic trioxide: an anti cancer missile with multiple warheads.
Q79358889Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis
Q30351531Artificial intelligence in hematology.
Q47683400Assessment of Apoptosis Regulating Factors BCL-2 and Fas Antigens on Malignant and Normal Plasma Cells.
Q54135363Assessment of Clonality and Its Relevance in Acute Myeloid Leukaemia and Bone Marrow Transplantation.
Q87903678Assessment of Prognostic Factors in 102 Patients with Myelodysplastic Syndrome-Osteoblasts are Related to Survival
Q33440206Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model
Q47327066Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia.
Q88383496Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study
Q44545376Assessment of neutrophil apoptosis ex vivo in hepatosplenic patients with neutropenia pre and post splenectomy.
Q46934229Association between Duffy antigen receptor expression and disease severity in sickle cell disease patients.
Q28248522Association between NOD2 single nucleotide polymorphisms and Grade III-IV acute graft-versus-host disease: A meta-analysis
Q51759896Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.
Q51020565Association between endothelial dysfunction and otoneurological symptoms in children with sickle cell disease.
Q86415316Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency
Q96583328Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease
Q35223500Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis
Q98387832Association between sickle cell disease and dental caries: a systematic review and meta-analysis
Q91628722Association between tumor necrosis factor alpha gene polymorphisms and multiple myeloma risk: an updated meta-analysis
Q90866123Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients
Q38991152Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients
Q44935412Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India
Q47669674Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans
Q57466926Association of cytotoxic T-lymphocyte antigen 4 gene with immune thrombocytopenia in Chinese Han children
Q91522447Association of diabetes mellitus with non-Hodgkin lymphoma risk: a meta-analysis of cohort studies
Q40579924Association of homocysteine and inflammatory-related molecules in sickle cell anemia
Q87898614Association of human platelet antigen polymorphisms with platelet count and mean platelet volume
Q34466198Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease
Q39851554Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy
Q40043606Associations between the HLA-A/B/DRB1 polymorphisms and aplastic anemia: evidence from 17 case-control studies
Q89918221Atrial fibrillation in beta thalassemia major: how to perform effective screening and early detection
Q35080336Auto-immune haemolytic anaemia--a high-risk disorder for thromboembolism?
Q57655174Autoimmune hemolytic anemia
Q40484487Autoimmune hemolytic anemia in India: clinico-hematological spectrum of 79 cases
Q33382854Autoimmune thrombocytopenia related to chronic hepatitis C virus infection.
Q33375992Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes
Q44440141Autologous Peripheral Blood Stem Cell Transplantation in First Remission Adult Acute Myeloid Leukaemia--An Intention to Treat Analysis and Comparison of Outcome Using a Predictive Model Based on the MRC AML10 Cohort
Q79839429Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience
Q48428886Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosis.
Q36868599Autologous peripheral stem cell transplant for POEMS syndrome: a case report
Q38859056Autophagy governs erythroid differentiation both in vitro and in vivo
Q39355488Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes
Q36328407B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis
Q39241720BCL11B suppression does not influence CD34(+) cell differentiation and proliferation
Q38154292BCR-ABL inhibitors: updates in the management of patients with chronic-phase chronic myeloid leukemia
Q33337686BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy
Q45877851BMT: Fractionation of Gene Modified Hematopoietic Autografts into Multiple Weekly Infusions Does Not Improve Engraftment in Unconditioned Canine Recipients
Q74000616BMT: Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study
Q47907052Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience
Q34780626Bcl-2 family members as prognostic indicators in AML.
Q92854354Beta-thalassemia: renal complications and mechanisms: a narrative review
Q88554694Better alternatives to permuted block randomization for clinical trials with unequal allocation
Q50646800Beyond diagnosis: subjective theories of illness in adult patients with acute myeloid leukemia.
Q38006844Beyond patient benefit: clinical development in hemophilia.
Q50711125Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia.
Q86075610Bioinformatics analysis of gene expression profiles in childhood B-precursor acute lymphoblastic leukemia
Q39962163Bioinformatics analysis of molecular mechanism of the expansion of hematopoietic stem cell transduced by HOXB4/HOXC4.
Q36270075Biology and prognostic factors in CLL.
Q46328753Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children
Q33400768Bleeding in the antiphospholipid syndrome
Q45840460Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues
Q50905261Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period.
Q33371428Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura
Q102064404Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway
Q36269972Blood transfusion and alternatives in elderly, malignancy and chronic disease
Q47211906Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study.
Q59312604Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements afte
Q34278284Bone Marrow TransplantationCurrent Clinical Practice: High-Dose Chemotherapy and Stem Cell Transplantation for Non-Hodgkin's Lymphoma: Review of Recent Advances
Q82835019Bone involvement in pediatric non-Hodgkin's lymphomas
Q33358037Bone marrow and peripheral blood C-kit ligand concentrations in patients with thrombocytosis and thrombocytopenia.
Q45767936Bone marrow angiogenesis in aplastic anemia--a study of CD 34 and VEGF expression in bone marrow biopsies
Q83903715Bone marrow failure and the new telomere diseases: practice and research
Q53666308Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia.
Q86878728Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia
Q85071744Bone marrow metastasis by solid tumors--probable hematological indicators and comparison of bone marrow aspirate, touch imprint and trephine biopsy
Q38125795Bone marrow neoplastic niche in leukemia
Q80454234Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma
Q33396250Bortezomib in patients with renal impairment
Q42252921Brain abscess caused by Nocardia cyriacigeorgica in two patients with multiple myeloma: novel agents, new spectrum of infections
Q38003011Breakthroughs in myeloproliferative neoplasms
Q40455179Breast lump as an initial manifestation in acute lymphoblastic leukemia: an unusual presentation. A case report.
Q39477239Bypassing the maturation arrest in myeloid cell line U937 by over-expression of microRNA-424.
Q37125164C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation
Q44488860C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease
Q48223642CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms.
Q45154626CD133-2 (AC141) expression analysis in acute leukemia immunophenotyping in correlation to CD34 and P-glycoprotein
Q84289192CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value
Q40376093CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia
Q38894006CD34 Selection and EX Vivo Expansion of Haemopoietic Progenitor Cells: A Review of Laboratory Methodology
Q36194534CD38 as a prognostic marker in CLL.
Q84429880CD56-positive diffuse large B-cell lymphoma: possible association with extranodal involvement and bcl-6 expression
Q38884580CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis
Q80454240CMED in the treatment of nasal natural killer cell lymphoma with distant metastases
Q57214187CML treatment in Asia-Pacific region
Q46870842CUPRAC-BCS and antioxidant activity assays as reliable markers of antioxidant capacity in erythrocytes
Q52665138Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations.
Q49072427Calreticulin mutation profile in Indian patients with primary myelofibrosis.
Q48212811Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?
Q50574609Can ischemia-modified albumin be a valuable indicator of tissue ischemia in polycythemia vera?
Q46290162Can mean platelet component be used as an index of platelet activity in stable coronary artery disease?
Q86396872Can threshold for MPO by flow cytometry be reduced in classifying acute leukaemia? A comparison of flow cytometric and cytochemical myeloperoxidase using different flow cytometric cut-offs
Q35126987Cancer Therapy: New Targets for Chemotherapy
Q81271293Cancer and the treatment: does it make sense to patients?
Q47364092Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies
Q38034291Carrier detection for beta-thalassemia trait in general Pakistani population: a way forward
Q33425012Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim
Q28300792Causes and consequences of the autoimmune lymphoproliferative syndrome
Q51742405Causes of microcytic anaemia and evaluation of conventional laboratory parameters in the differentiation of erythrocytic microcytosis in blood donors candidates.
Q54123650Cell proliferation and inhibition of apoptosis are related to c-Kit activation in leukaemic lymphoblasts.
Q81409256Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome
Q45242524Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases
Q37293534Central nervous system involvement in adult acute lymphoblastic leukemia
Q87920481Cephalosporin-induced Hemolytic Anemia in a Sicilian Child
Q74000786Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis
Q46302985Challenges in the management of sickle cell disease during pregnancy in Senegal, West Africa.
Q46002196Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma.
Q87282614Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients
Q40002190Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: A 9-year follow-up
Q80677029Changes of human B and B-1a peripheral blood lymphocytes with age
Q33441053Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study
Q44561492Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia
Q48181857Characteristics of bone marrow cell dysplasia and its effectiveness in diagnosing myelodysplastic syndrome
Q88559393Characteristics of fibrinolytic disorders in acute promyelocytic leukemia
Q47624350Characterization of Bone Marrow Stromal Cells.
Q44608849Characterization of Clonogenic Progenitors in Autologous Peripheral Blood Stem Cell Grafts: Evaluation of a Simple In Vitro Assay Suitable for Routine Clinical Use
Q43620861Characterization of conserved CDR3 sequence of TCR alpha- and beta-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma
Q87876091Chromosome 7 and Haematological Malignancies
Q36270036Chromosome copy number and leukemia-lessons from Down's syndrome
Q87879331Chronic Lymphocytic Leukemia: An Update on Current Treatment Approaches
Q87896115Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management
Q80376709Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation
Q33404481Chronic immune thrombocytopenic purpura in childhood: pathogenetic mechanisms and management
Q33343670Chronic lymphocytic leukaemia--the haematologic basis for diagnosis and treatment
Q87173907Chronic lymphocytic leukemia
Q33375516Chronic lymphocytic leukemia in India--a clinico-hematological profile
Q46214120Chronic myeloid leukaemia in South Africa.
Q87655649Chronic neutropenia
Q40697247Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease
Q79125132Circulating Blasts Following Chemotherapy in Pediatric Patients: Implications for Complete Remission Definition in Acute Leukemia
Q53433792Circulating T cells derived from acute leukemia patients with severe therapy-induced cytopenia express a wide range of chemokine receptors.
Q80454221Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex
Q44108311Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences
Q74597209Circulating thrombopoietin in clonal versus reactive thrombocytosis
Q87367116Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report
Q38896677Clinical Applications of Automated Reticulocyte Indices
Q87896117Clinical Regression and Remission of Primary Refractory Angiocentric Lymphoma Following Autologous Tumour Peptide Antigen-charged Dendritic Cells After High-dose Chemotherapy and Autologous Stem Cell Rescue
Q97540800Clinical analysis and literature review of a case with the myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
Q51061264Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.
Q44765612Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia
Q38399929Clinical and pathological features of head and neck follicular dendritic cell sarcoma
Q39851532Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia.
Q47568416Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study
Q90181016Clinical characteristics and prognostic factors in Chinese patients with classical Hodgkin's lymphoma involving extranodal sites: a retrospective single-center
Q92680673Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study
Q103720497Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations
Q30252222Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
Q40692620Clinical efficacy and safety of ruxolitinib in the management of myelofibrosis: A single institution experience in Taiwan
Q89530499Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database
Q50697626Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation.
Q45227780Clinical features of de novo CD25(+) diffuse large B-cell lymphoma
Q50631404Clinical impact of SNP of P53 genes pathway on the adult AML patients.
Q35809452Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation
Q92910684Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero
Q52730056Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement.
Q84559374Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis
Q54452862Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders.
Q87432673Clinical significance of interleukin-22 in multiple myeloma
Q40426902Clinical significance of the ABCB1 and ABCG2 gene expression levels in acute lymphoblastic leukemia.
Q50736205Clinical usefulness of FDG-PET/CT for the evaluation of various types of adult T-cell leukemia.
Q118149852Clinical utility of the updated European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and the Mycoses Study Group Education and Research Consortium computed tomog
Q91686153Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience
Q43173260Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population
Q36270096Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond
Q51035365Clinico-haematological profile of HbE syndrome in adults and children.
Q45985682Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India.
Q40318435Clinicohaematological profile of infections in bone marrow - single centre experience in North Himalayan region of India
Q41466915Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis
Q91892902Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma
Q91925252Clonal evolution in a chronic neutrophilic leukemia patient
Q53528275Clonal evolution with +11q 13, t(1;7) and t(1;4) at relapse in a patient with Ph positive acute lymphocytic leukemia (ALL) treated with single agent front line imatinib followed by dasatinib.
Q80376747Clonal expanded TCR Vbeta T cells in patients with APL
Q84118966Clonal expanded TRA and TRB subfamily T cells in peripheral blood from patients with diffuse large B-cell lymphoma
Q46639199Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia
Q35605112Clopidogrel: interactions with the P2Y12 receptor and clinical relevance
Q45856286Co-expression of B7-1 with Interleukin-12 Enhances Vaccine-induced Antitumour Immunity in Experimental Myeloma
Q47441469Co-inheritance of HBB:c.-106G > C, a rare single nucleotide variation at position -56 relative to transcription initiation site, with other known mutations in the globin clusters
Q81409273Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran
Q38855974Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt
Q46600565Coagulopathy, following medical therapy, for carcinoma of the prostate
Q47683726Coexistence of Polycythaemia Vera with Indolent Myeloma in the same Patient
Q87875742Coexistent Polycythemia Vera and Chronic Lymphocytic Leukemia: Down-Regulation of Myeloid Clone by the Lymphoid Clone?
Q89547264Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients
Q80205130Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy
Q33429973Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failure
Q42878312Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia--a report of five cases
Q38798789Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis
Q36269980Combined use of oral chelators and desferrioxamine in thalassemia.
Q47618462Commentary of Involvement of E-Cadherin in the Development of Erythroid Cells, Armeneau et al.
Q90732492Common themes and challenges in hemophilia care: a multinational perspective
Q86429056Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction
Q87903674Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT?
Q33434838Comparative analysis of iron status and other hematological parameters in preeclampsia.
Q62090477Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation
Q47429711Comparative evaluation of oral and dento-maxillofacial manifestation of patients with sickle cell diseases and beta thalassemia major
Q39198051Comparative haematological parameters of HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen
Q91110925Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity
Q84289223Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea
Q61913903Comparing techniques: the use of recalcified plasma in comparison with citrated plasma alone and in combination with thrombin in ultrastructural studies
Q46600586Comparison for functional aberration of G-6-PD deficiency variants with exon 10 mutations
Q87879592Comparison of Rai and Binet Classifications in Chronic Lymphocytic Leukemia
Q104749499Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
Q40895560Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimens
Q81203967Comparison of cost effectiveness between measuring the serum erythropoietin level and reticulocyte count for monitoring thalassemic patients: a note in Thai beta thalassemia/Hb E subjects
Q39794860Comparison of diagnostic criteria for polycythaemia vera
Q50485190Comparison of discriminative indices for iron deficiency anemia and β thalassemia trait in a Brazilian population.
Q35989647Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas
Q52631905Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children.
Q84559362Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases
Q53650174Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia.
Q86052595Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia
Q37149765Complications of sickle cell anaemia in children in Northwestern Tanzania
Q92725016Compound heterozygous mutations Glu502Lys and Met527Thr of the FXII gene in a patient with factor XII deficiency
Q45878579Comprehensive care in hemophilia
Q97434323Comprehensive screening for coexisting heterozygous α0-thalassemia in hemoglobin E trait
Q47618454Concluding Annotation to Armeneau et al.
Q47622084Concluding Annotation to Hahn et al.
Q47622110Concluding Annotation to Ploemacher et al.
Q47618472Concluding Annotation to Torensma et al.
Q33413602Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia
Q46466971Concurrent audit of fresh frozen plasma: experience of a tertiary care hospital
Q44299199Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia
Q36270161Congenital bone marrow failure involving the red blood cells
Q42216426Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
Q40001157Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation
Q90757775Congenital fibrinogen disorder caused by digenic mutations of the FGA and FGB genes
Q81271283Congenital neutropenias
Q53132506Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed.
Q88284783Contrasting co-inheritance of alpha and beta mutations in delta beta thalassemia and hereditary persistence of fetal hemoglobin: a study from India
Q63240981Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population
Q87875754Controversies Around Vitamin B12 in Sweden
Q83903830Cord blood banking: current status
Q81474341Cord blood transplantation and cord blood banking
Q95407249Correction
Q95410273Correction
Q91165529Correlation between RBC changes and coagulation parameters in high altitude population
Q58814522Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI
Q43980276Correlation between flow cytometric identification of CD33-positive cells and morphological evaluation of myeloblasts in bone marrow of patients with acute myeloblastic leukemia
Q54399795Correlation of beta-thalassemia mutations with alpha-thalassemia: an experience of the southwestern region of Iran.
Q87912689Correlations Between Iron Status Markers During Normal Pregnancy in Women with and without Iron Supplementation
Q88671797Corrigendum
Q89229913Corrigendum
Q89917867Corrigendum
Q95364100Corrigendum
Q95423099Corrigendum
Q95614402Corrigendum
Q40643748Cost Effectiveness of G:CSF in Chemotherapy and Transplant-related Neutropenia
Q98780081Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab
Q46556375Could mean platelet volume be a predictive marker for gestational diabetes mellitus?
Q43649407CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients
Q91058801Cross-sectional physician survey on the use of minimal residual disease testing in the management of pediatric and adult patients with acute lymphoblastic leukemia
Q63241039Cultural factors related to adherence to imatinib in CML: A Mexican perspective
Q39908969Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia
Q35126998Current Clinical Practice DIC 2002: A Review of Disseminated Intravascular Coagulation
Q47683100Current Clinical Practice: Application of Resistance Reversal Agents in Hematologic Malignancies
Q54394972Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura.
Q46861704Current Clinical Practice: Hereditary Haemochromatosis: Recent Advances in Biology and Management
Q47273612Current Clinical Practice: Low-Molecular-Weight Heparins in The Prophylaxis and Treatment of Thrombo-Embolic Disease
Q38897813Current Management in Sickle Cell Disease
Q74000705Current Perspectives on the Use of Growth Factors in the Therapy of Acute Myeloid Leukaemia; Malignancy
Q38894036Current Practice in the Treatment of Haemophilia
Q38897680Current Treatment of Chronic Myeloid Leukemia
Q46541276Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists
Q36269952Current update on reduced intensity regimens for allogeneic stem cell transplantation
Q46226742Cyclin D1 expression in acute leukemia
Q53543241Cyclin Dl expression in B-cell non Hodgkin lymphoma.
Q44537232Cytochemical, immunophenotypic and ultrastructural characterization of acute leukemias: a prospective study of fifty cases: haematological malignancy
Q37888830Cytogenetic abnormalities in myelodysplastic syndrome: an overview
Q94450638Cytogenetic abnormalities in patients with newly diagnosed multiple myeloma as a secondary primary malignancy: a retrospective study
Q39025570Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia
Q81409268Cytogenetic profile of acute lymphocytic leukemia patients: report of a novel translocation t(4;13) (q21 x 3; q35) from an Indian population
Q38896511Cytokine Dysregulation in Acute Graft-versus-Host Disease
Q53666438Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease.
Q40610275Cytokines and Cytomegalovirus Disease Following Allogeneic Bone Marrow Transplantation
Q87901913Cytokines in Platelet Concentrates
Q35552533Cytokines in sickle cell disease
Q33367711Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult effectively treated with intravenous immunoglobulin: a case report and review
Q39286256Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription
Q86820967D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine
Q81271201DLI: where are we know?
Q34581359DNA microarray analysis: principles and clinical impact
Q28255746DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients
Q50055097Danazol increases T regulatory cells in patients with aplastic anemia.
Q83649610Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD
Q84974303Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP
Q44440137Decreased Transfusion Requirements in Patients Given Stem Cell Allografts Using a Non-myeloablative Conditioning Regimen: A Single Institution Experience
Q104615188Decreased bone marrow regulatory innate lymphoid cells show a distinctive miRNA profiling in aplastic anemia
Q85657330Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis?
Q40062807Decreased levels of Th17 cells are associated with invasion fungal infections after allogeneic hematopoietic stem cell transplantation
Q41578421Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinib
Q88099141Deep vein thrombosis
Q83304131Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients
Q35127001Dendritic cell-based immunotherapy for the treatment of hematological malignancies
Q37293529Dengue virus related hemophagocytosis: a rare case report
Q91145591Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis
Q38880958Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes
Q47684162Detection and Identification of Single Molecules in Immunology and Immunohematology: Single (solution)-phase Single-molecule FCS.
Q44765944Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib.
Q45393748Detection of Epstein-Barr virus in children and adolescents with Burkitt's lymphoma by in situ hybridization using tissue microarrays
Q73093751Detection of erythrocytes deficient in glycosylphosphatidyl-inositol anchored membrane proteins in patients with paroxysmal nocturnal hemoglobinuria by the toxin HEC secreted by Aeromonas hydrophila J-1
Q82653393Determination of donor-derived killer immunoglobulin-like receptor (KIR) by sequential genotyping in hematopoietic stem cell-transplanted patients
Q54532003Development of Dermatomyositis in a Patient with Primary Myelofibrosis.
Q84957605Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia
Q84991918Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up
Q92468697Diagnosis and treatment of juvenile myelomonocytic leukemia
Q38808158Diagnosis of factor XIII deficiency
Q46490985Diagnosis of multiple myeloma using enzyme immunoassay for detection of antibodies to N-acetyl glucosamine on microparticles
Q30239758Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.
Q64914983Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base.
Q81271152Diagnostic approaches to bleeding disorders
Q58596822Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia
Q102064422Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic Leukemia
Q79839446Diamond-Blackfan anemia: clinical features and treatment results in 4 cases
Q100951755Diaphragm ultrasonography in adults with sickle cell anemia: evaluation of morphological and functional aspects
Q82653407Diet and iron deficiency in the first year of life: a retrospective study
Q47642100Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience.
Q91817255Differences in pulmonary and extra-pulmonary characteristics in severely versus non-severely fatigued recipients of allogeneic hematopoietic stem cell transplantation: a cross-sectional, comparative study
Q40835352Different Mechanisms of Resistance to Lymphokine-activated Killer (LAK) Cells in Leukemic Cell Sublines Selected by Etoposide or by LAK Cells.
Q91128117Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails
Q43905145Diffuse large B-cell lymphoma primary of lung.
Q92959167Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer
Q93253518Disappearance of monosomy 7 in a patient with aplastic anemia after eltrombopag treatment
Q91628698Disordered bone metabolism in hereditary spherocytosis patients
Q45055513Distribution of alpha-thalassemia mutations in Iranian population.
Q92949398Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region
Q36221531Divalent metal transporter 1.
Q38899401Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy?
Q46600561Do alpha deletions influence hydroxyurea response in thalassemia intermedia?
Q39843822Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells
Q51759891Does mobilization for autologous stem cell transplantation damage stromal layer formation?
Q41717778Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis?
Q92449544Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation
Q83903760Donor cell leukemia
Q47606016Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients.
Q47327078Dose dependent long-term in vivo remission of AML1/ETO positive acute myeloid leukemia with G-CSF.
Q47195077Double vs. single cord blood transplantation in adolescent and adult hematological malignancies with heavier body weight (≥50 kg).
Q33960952Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.
Q39477519Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance
Q57462914Dr. S. Mitchell Lewis 1924-2018
Q36868609Duffy blood group and malaria
Q58596834Dysfunction of immune system in the development of large granular lymphocyte leukemia
Q49616958Dyspareunia is associated with chronic pain in premenopausal women with sickle cell disease.
Q53630999Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma.
Q43926355EPAS1 p.M535T mutation in a Bulgarian family with congenital erythrocytosis
Q36892389ESR or CRP? A comparison of their clinical utility
Q86508090EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate
Q82784917Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disorders
Q59245121Early infections in patients undergoing high-dose treatment with stem cell support: a comparison of patients with non-Hodgkin lymphoma and multiple myeloma
Q53568897Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders.
Q40794987Early mortality in multiple myeloma: Experiences from a single institution
Q91582996Economic burden of hemophilia A and B: a case in Iran
Q83903838Economic evaluation of hematopoietic stem cell transplantation
Q95461849Editorial
Q95464393Editorial
Q47624362Editorial Comment: Heterogeneity of Bone Marrow Stromal Cells Editorial Comment on Dr. Waller's Paper
Q87912919Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy
Q47618443Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy.
Q53160078Editorial. Hematology as the official journal of the International Society of Hematology.
Q83304127Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells
Q87879336Effect of GM-CSF, 1, 25-Dihydroxycholecalciferol (Vit.D) and All-Trans-Retinoic Acid (ATRA) on the Proliferation and Differentiation of MDS-Bone Marrow (BM)-Cells In Vitro
Q33386715Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura
Q87910577Effect of Interferon-α on Patients with Previously Untreated Chronic Myelogenous Leukemia in the Early Chronic Phase: Comparison between Interferon-α Continued Patients and Interferon-α Discontinued Patients
Q61942748Effect of Interleukin-1 α and Interleukin-1 β on Erythroid Progenitor Cell Growth in Serum Free Cultures: An In Vitro Study Relevant to the Pathogenesis of the Anemia of Chronic Disease
Q45918792Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate.
Q50692102Effect of gamma irradiation on blood from glucose 6 phosphate dehydrogenase deficient blood donors.
Q42878309Effect of general and epidural anesthesia on hemostasis and fibrinolysis in hepatic patients.
Q33401131Effect of glucose-6-phosphate dehydrogenase deficiency on some biophysical properties of human erythrocytes
Q91987919Effect of iron chelation therapy on EPO-STAT5 signalling pathway and EPO resistance in iron-overloaded low-risk myelodysplastic syndrome patients
Q33401584Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia
Q46181753Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning
Q48118195Effect of transfusion on cerebral oxygenation, flow velocity in a patient with sickle cell anemia and Moyamoya disease: a case report
Q45985680Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxide oxidative damage in human erythrocytes.
Q50985408Effect of zinc supplementation on serum antibody titers to heat shock protein 27 in patients with thalassemia major.
Q51009847Effect on haematological and anthropometric parameters of iron supplementation in the first 2 years of life. Risks and benefits.
Q83649640Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients
Q40441775Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma
Q35104606Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis
Q45931931Effects of aGVHD and cGVHD according to relapse status on survival rate in patients with acute lymphocytic leukemia.
Q50711119Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes.
Q90049083Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction
Q89066665Effects of nitric oxide donor S-nitrosoglutathione on apoptosis of apheresis platelets
Q33385549Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura
Q33391987Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia
Q93385650Efficacy and safety of bispecific T-cell engager (BiTE) antibody blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin's lymphoma: a systemic review and meta-analysis
Q41705410Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study.
Q104567126Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia
Q104470376Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation
Q33375988Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura
Q90203934Efficacy and safety of iron chelator for transfusion-dependent patients with myelodysplastic syndrome: a meta-analysis
Q90463132Efficacy and safety of second-line treatment in Thai patients with primary warm-type autoimmune hemolytic anemia
Q90911404Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma
Q92424234Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis
Q47654837EgoNet identifies differential ego-modules and pathways related to prednisolone resistance in childhood acute lymphoblastic leukemia
Q33413850Elevated levels of T-cell immune response cDNA 7 in patients with immune thrombocytopenia
Q48097217Elevated plasma asymmetric dimethylarginine levels in children with beta-thalassemia major may be an early marker for endothelial dysfunction.
Q46779569Elevated platelet microparticle levels in valvular atrial fibrillation
Q53467101Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia.
Q50724520Elevation of CD16+CD56+ NK-cells and down-regulation of serum interleukin-21 (IL-21) and IL-1α after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause.
Q74627666Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia
Q58131560Eliezer Rachmilewitz (1935-2017)
Q48305083Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.
Q99353696Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia
Q46374577Endocrine effects of erythropoietin in cancer patients
Q87879608Endogenous Erythropoietin, Tumor Necrosis Factor-α and Interleukin-6 Levels after Peripheral Blood Stem Cell Transplantation
Q46687489Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease
Q87879056Enhanced Erythropoietin Response to Acute Hypoxemia in Mice with Pharmacological Depression of Erythropoiesis
Q44765614Enhanced neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis: evidence of serum Fas ligand
Q39710209Enhancement of specific cellular immune response induced by DNA vaccines encoding PML-RARalpha and hIL-2 genes
Q36328391Enhancing siRNA effects in T cells for adoptive immunotherapy
Q34234557Ensuring maximum outcomes and benefits in comprehensive care for bleeding disorders through surveillance and data collection
Q40113207Epidemiologic study of major complications in adolescent and adult patients with thalassemia in Northeastern Thailand: the E-SAAN study phase I.
Q38896595Epidemiology of Multiple Myeloma
Q92449930Epidemiology of aplastic anemia: a study of 1324 cases
Q43689745Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders
Q59357918Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center
Q40559190Eradication of Invasive Mucormycosis--Effectiveness of the Echinocandin FK463
Q87852864Erratum
Q95439524Erratum
Q34875235Erythroblast iron metabolism in sideroblastic and sideropenic states
Q81243522Erythrocyte CD38 as a prognostic marker in cancer
Q54586615Erythrocyte Deformability is Reduced and Fragility increased by Iron Deficiency.
Q42952353Erythrocyte membrane defects and asymmetry in paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome
Q50505304Erythrocyte membrane protein defects in hereditary spherocytosis patients in Turkish population.
Q74000653Erythrocytes: Anemias in Chronic Liver Diseases
Q42651785Erythrocytes: Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia
Q50477058Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients.
Q74000532Erythropoiesis: Case Report: Congenital Dyserythropoietic Anemia Type II in a Woman Presenting with Jaundice, Anemia, and Splenomegaly
Q74000437Erythropoiesis: Comparison of Cytotoxic Aldehyde Generation in Beta-Thalassemia Patients Chelated with Deferoxamine or Deferiprone (L1) Versus NO Chelation
Q74000630Erythropoiesis: Correlations Between Iron Status Markers During Normal Pregnancy in Women with and without Iron Supplementation
Q34278265Erythropoiesis: Current Clinical Practice: Advances in the Genetics and Biology of Fanconi Anaemia
Q46233196Erythropoiesis: Erythrocyte Deformability is Reduced and Fragility increased by Iron Deficiency
Q30654000Erythropoiesis: Hereditary Spherocytosis in Greece: Collective Data on a Large Number of Patients
Q28201102Erythropoiesis: Paroxysmal Cold Haemoglobinuria: A Clinico-Pathological Study of Patients with a Positive Donath-Landsteiner Test
Q74000441Erythropoiesis: Pyruvate Kinase Deficiency which Causes Nonspherocytic Hemolytic Anemia: The Gene and its Mutations
Q34278250Erythropoiesis: Review Article: Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of beta-Thalassemia and Sickle Cell Disease.
Q74000465Erythropoiesis: Short Report: Translation of Analysis Results between Serum Ferritin Assays, Ferritin RIA AmershamTM and Abbott AxSYMTM Ferritin
Q30662837Erythropoiesis: Splenic Immunoglobulin Variable Region Genes Encoding Red Blood Cell Binding Fab Fragments in Autoimmune Hemolytic Anemia
Q38690833Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysis
Q86829788Essential thrombocythaemia
Q35022117Essential thrombocythemia (ET): moving from palliation to cure
Q34875212Essential thrombocythemia: diagnosis and treatment, with special emphasis on the use of anagrelide
Q54156955Estimated Blood Loss in Group O as Compared to Non-group O Radical Prostatectomy Patients.
Q30244579Estimation of iron deficiency anemia in Iranian children and adolescents: a systematic review and meta-analysis.
Q87896127Estimation of the Infectious Risks of Blood Transfusion
Q47651447Estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma.
Q122998475Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients
Q92484137Etiology and clinico-hematological profile of pancytopenia: experience of a Mexican Tertiary Care Center and review of the literature
Q36270040Etiopathogenesis of pediatric thrombosis
Q101161627Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review
Q54565302European Concerted Action on Anticoagulation (ECAA): Clinical and Laboratory Studies.
Q35197156Evaluating the effectiveness of epoetin alfa in community oncology practices
Q53617967Evaluation of IGK and IGL molecular gene rearrangements according to the BIOMED-2 protocols for clinical diagnosis of Hodgkin lymphoma.
Q46321468Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance
Q80677021Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells
Q84753707Evaluation of an immunoturbidimetric D-dimer assay and pretest probability score for suspected venous thromboembolism in a district hospital setting
Q38855963Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt
Q36285290Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging
Q82653369Evaluation of factors associated with recruitment in hematological clinical trials: a retrospective cohort study
Q45298325Evaluation of growth parameters in patients with thalassemia major
Q88070196Evaluation of hypercoagulability with rotational thromboelastometry in children with iron deficiency anemia
Q47666649Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia
Q87343843Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients
Q36328397Evaluation of pulmonary infiltrates in patients after stem cell transplantation
Q53791893Evaluation of serum and urine fetuin-A levels in children with acute lymphoblastic leukemia during and after high-dose methotrexate therapy: Relation to toxicity.
Q42208353Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.
Q44310694Evaluation of umbilical cord blood CD34 (+) hematopoietic stem cell expansion in co-culture with bone marrow mesenchymal stem cells in the presence of TEPA.
Q33382284Evans syndrome: a study of six cases with review of literature
Q36276288Evolving molecular therapy for chronic myeloid leukaemia--are we on target?
Q36892384Exertional rhabdomyolysis and renal failure in patients with sickle cell trait: is it time to change our approach?
Q51688921Existence of cord compression in extramedullary hematopoiesis due to beta thalassemia intermedia.
Q40835347Exogenous PML/RARα Fusion Gene Responds to All-trans Retinoic Acid Results in Differentiation of the Human B Cell Line
Q53240284Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Q89264404Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia
Q93006968Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage
Q96948152Expression and clinical significance of phospholipase D1 in de novo acute myeloid leukemia
Q44009000Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia
Q54244119Expression and promoter methylation changes of the P15INK4b during ex vivo cord blood CD34+ cell expansion following co-culture with mesenchymal stromal cells.
Q48233285Expression and role of granulocyte macrophage colony-stimulating factor receptor (GM-CSFR) and granulocyte colony-stimulating factor receptor (G-CSFR) on Ph-positive acute B lymphoblastic leukemia.
Q34278892Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia
Q92492517Expression of BTK/p-BTK is different between CD5+ and CD5- B lymphocytes from Autoimmune Hemolytic Anemia/Evans syndromes
Q33424522Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura.
Q39296772Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults
Q45856281Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation.
Q44964318Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells
Q54442929Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma?
Q79964224Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia
Q87597955Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia
Q79964216Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias
Q90175412Expression of serum BMP6 and hepcidin in cancer-related anemia
Q46551442Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study
Q38763444Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma
Q50228191Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease.
Q81271211External quality assessment scheme by private laboratories in Turkey
Q41450891Extracellular accumulation of bioactive substances; interleukin-1beta (IL-1beta) and plasminogen activator inhibitor-1 (PAI-1) in stored blood units and relation to bacterial contamination
Q114098159Extracorporeal photopheresis for the treatment of chronic graft versus host disease
Q81783314Extranodal lymphoma: a comparative study
Q87911034Extreme Thrombocytosis after Penetrating Femoral Venous Injury
Q48299475FC gamma receptor polymorphisms in patients with immune thrombocytopenia.
Q63440154Facilities for the treatment of adults with haematological malignancies – 'Levels of Care': BCSH Haemato-Oncology Task Force 2009
Q39447734Factor V Leiden and prothrombin gene mutations in Egyptian cases with unexplained recurrent pregnancy loss
Q53655617Factor V Leiden detection by polymerase chain reaction-restriction fragment length polymorphism with mutagenic primers in a multiplex reaction with Pro G20210A--a novel technique.
Q91326508Factor VII deficiency - an enigma; clinicohematological profile in 12 cases
Q33394560Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin
Q39103011Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes
Q38855960Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province
Q87903094Familial Myelodysplastic Syndrome/Acute Myeloid Leukaemia With Monosomy 7: Report of a New Kindred
Q36269999Fanconi anemia: current management
Q41378115Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders
Q57518582Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia
Q33433926Fatal Pancreatic Necrosis after Pregnancy-Associated Thrombotic Thrombocytopenic Purpura
Q33365360Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy
Q51817075Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion.
Q45848074Features and clinical outcomes in 40 patients with mixed-lineage acute leukemia in a single center
Q36270114Febrile neutropenia--seven frequently asked questions and answers
Q40210717Febrile neutropenia: median door-to-needle time - results of an initial audit
Q87910588Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells)
Q87903097Fibrin Glue for Bleeding Peptic Ulcers
Q39939244Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5.
Q91683308Ficolled bone marrow is superior to bone marrow buffy coat for detection of minimal residual disease in multiple myeloma
Q81243475First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers
Q81409276First report of a nonsense mutation at codon 15(TGG-->TAG) in exon 1 of the beta globin gene in a beta thalassemia trait in State of Orissa, India
Q54542083First reported case of prenatal diagnosis for pyruvate kinase deficiency in a Chinese family.
Q86065324Fish consumption and risk of non-Hodgkin lymphoma: A meta-analysis of observational studies
Q81243531Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy
Q47885241Flow cytometric analysis of patients with hereditary spherocytosis - an Indian scenario
Q53036476Flow cytometric assessment of endothelial and platelet microparticles in preeclampsia and their relation to disease severity and Doppler parameters.
Q44096697Flow cytometric comparison of platelets from a whole blood and finger-prick sample: impact of 24 hours storage
Q35809442Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes
Q87879792Fluorescence In Situ Hybridization: Trisomy 12 Follow-up In Hairy Cell Leukemia
Q83504858Fluorescent in situ hybridization studies in multiple myeloma
Q83304162Fok-I gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status
Q33367708Fondaparinux: a potential new therapy for HIT.
Q45856357Fractionation of Gene Modified Hematopoietic Autografts into Multiple Weekly Infusions Does Not Improve Engraftment in Unconditioned Canine Recipients
Q84957604Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia
Q39447770Frequency of factor V Leiden mutation in Egyptian cases with myocardial infarction.
Q91628691Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome
Q54306982Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations.
Q59423170Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up
Q58050726Frontline treatment of multiple myeloma
Q38731027Fusion genes in malignant neoplastic disorders of haematopoietic system
Q87876109G CSF: A First Line Therapy for Autoimmune Neutropenia?
Q74000725G-CSF Primed Autologous Marrow Harvest and Transplantation in Cytapheresis "Mobilization Failure" Patients: A Descriptive Analysis; Bone Marrow Transplantation
Q87879803G-CSF Regulates the Expression of mRNA for Collagen Type VI and Collagen VI Production in Human Bone Marrow Stromal Cells
Q86317992G-CSF induces up-regulation of CXCR4 expression in human hematopoietic stem cells by beta-adrenergic agonist
Q50732902G6PD deficiency with hemolytic anemia due to a rare gene deletion--a report of the first case in Malaysia.
Q80677026GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia
Q40303868GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome.
Q91384499GDF11 is increased in patients with aplastic anemia
Q41240899GM-CSF Priming of U937 Monocytic Cells Accelerates, But Does Not Increase, Tissue Factor (TF) Expression or Procoagulant Activity (PCA) After Stimulation with Endotoxin (LPS).
Q86429007GPRC5D is a promising marker for monitoring the tumor load and to target multiple myeloma cells
Q40457696GSTT1 (rs4025935) null genotype is associated with increased risk of sickle cell disease in the populations of Tabuk-Northwestern region of Saudi Arabia.
Q38556887Gamma heavy chain disease associated with large granular lymphocytic leukemia: A report of two cases and review of the literature.
Q30244317Gaucher disease epidemiology and natural history: a comprehensive review of the literature.
Q61868130Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL)
Q36221521Gene expression profiling in the myelodysplastic syndromes
Q84616301Gene expression profiling of CD3gamma, delta, epsilon, and zeta chains in CD4(+) and CD8(+) T cells from human umbilical cord blood
Q35809458Generation of dendritic cells using cell culture bags--description of a method and review of literature
Q53378105Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity.
Q50994599Genetic analysis of a hereditary factor XII deficiency pedigree of a consanguineous marriage due to a homozygous F12 gene mutation: Gly341Arg.
Q37270864Genetic determinants of phenotype in beta-thalassemia.
Q38938998Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1.
Q36799622Genetically heterogeneous origins of idiopathic erythrocytosis
Q52594557Geographical distribution of β-globin gene mutations in Syria.
Q48368346Gestational age and childhood leukemia: A meta-analysis of epidemiologic studies
Q35552538Gfi-1 Oncoproteins in Hematopoiesis
Q33368667Giant platelet syndrome
Q51513959Gilbert's syndrome disclosed during the treatment of hematological malignancies.
Q34380139Glucose-6-phosphate dehydrogenase Guadalajara--a case of chronic non-spherocytic haemolytic anaemia responding to splenectomy and the role of splenectomy in this disorder
Q39260470Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
Q39691616Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity.
Q50794130Graft-versus-host disease confined solely to intestine after allogeneic peripheral blood stem cells transplantation in a patient with chronic myelogenous leukemia.
Q53751930Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced Neutropenia.
Q87879044Granulocyte-Macrophage Colony-Stimulating Factor in Newly Diagnosed Adult Patients with Acute Lymphoblastic Leukemia Treated with Conventional Chemotherapy
Q35809463Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines.
Q36307582Granulocytic adhesive interactions and their role in sickle cell vaso-occlusion
Q36270065Gray zone lymphomas
Q74000526Growth Factors: Production of Monocyte Chemotactic Protein-1 (MCP-1/JE) by Bone Marrow Stromal Cells: Effect on the Migration and Proliferation of Hematopoietic Progenitor Cells
Q33337681Growth Factors: Thrombopoietic Property of the Pineal Hormone Melatonin
Q38042777Guidelines on obtaining consent for systemic anti-cancer therapy in adults
Q46599911HFE gene mutation and iron overload in Egyptian pediatric acute lymphoblastic leukemia survivors: a single-center study.
Q38866780HLA class II polymorphism in Egyptian children with lymphomas
Q51759881HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker?
Q40428384HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin).
Q38897817HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A Review
Q38894418Haematologic Malignancy Secondary to the Treatment of Lymphoma
Q45863419Haematology clinic: Haemophilia A.
Q51127214Haemoglobin F, A2, and S levels in subjects with or without sickle cell trait in south-eastern Gabon.
Q85900169Haemolysis secondary to intravenous immunoglobulins for ITP
Q36844901Haemopoietic stem cell transplantation--an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology
Q74000596Haemostasis and Thrombosis: Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura
Q47208475Haemostasis and Thrombosis: Current Clinical Practice: Low-Molecular-Weight Heparins in The Prophylaxis and Treatment of Thrombo-Embolic Disease.
Q47683898Haemostatic Abnormalities in Patients with a Clinical Predisposition to Venous Thromboembolism
Q36269967Haemovigilance in developing countries
Q84965336Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation
Q87878043Handbook of Blood Transfusion Therapy, 2nd Edition
Q100547453Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis
Q41648349Haptoglobin genotypes polymorphism as a risk factor for subclinical atherosclerosis in beta-thalassemia major children; a single center Egyptian study
Q87876114Has Lactoferrin a Role in Hereditary Hemochromatosis?
Q50467588Hb A2 Episkopi - a novel δ-globin chain variant [HBD:c.428C>T] in a family of mixed Cypriot-Lebanese descent.
Q50485384Hb Koln [β98(FG5) [GTG → ATG, Val → Met]: the first report from India.
Q50459801HbF in HbE/β-thalassemia: A clinical and laboratory correlation.
Q52381951Health-related quality of life before and after hematopoietic stem cell transplant: evidence from a survey in Suzhou, China.
Q36194587Heat shock proteins and acute leukemias
Q51691220Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors.
Q101125635Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study
Q40907380Hematological Effects of Chernobyl In Belarus: Do They Really Exist Ten Years Later?
Q33375520Hematological presentation in systemic lupus erythematosus and its relationship with disease activity
Q40407333Hematological profile in pyrexia of unknown origin: role of bone marrow trephine biopsy vis-à-vis aspiration.
Q87938477Hematology clinic. Acute lymphoblastic leukemia
Q45286978Hematology clinic: chronic myelogenous leukemia
Q36270031Hematology education in a problem-based curriculum.
Q47326165Hematology morphology forum
Q73634897Hematology morphology forum
Q74627676Hematology morphology forum
Q80214608Hematology morphology forum
Q73093757Hematology morphology forum case 1. Granulocytic sarcoma
Q73390755Hematology morphology forum case 2. Mycobacterial spindle-cell pseudotumor of the lymph nodes
Q73795188Hematology morphology forum case 3. Chediak-Higashi syndrome
Q43880098Hematology morphology forum. Clostridium welchii septicemia.
Q45204117Hematology morphology forum. Paroxysmal cold haemoglobinuria
Q83903694Hematology. Editorial
Q81271235Hematomorphology
Q35809433Hematopoiesis in the elderly.
Q74000673Hematopoiesis: Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hemopoietic Stem Cells
Q40799505Hematopoiesis: The Role of Stromal Integrin Interactions in Pro-B Cell Proliferation
Q40907374Hematopoietic Growth Factors and Blast Progenitors in Acute Leukemia
Q54515818Hematopoietic cell transplantation for chronic myeloid leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era.
Q46820835Hematopoietic cell transplantation in Latin America
Q36868596Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature
Q83903832Hematopoietic stem cell transplantation in Europe. Differences between Eastern and Western countries
Q40632418Hematopoietic stem cell transplantation: the Vancouver experience
Q37854920Hematopoietic stromal cells and megakaryocyte development
Q38848661Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia
Q40800759Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome.
Q84429884Hemoglobin D-Punjab syndromes in India: a single center experience on cation-exchange high performance liquid chromatography
Q80677033Hemoglobin E disease in North Indian population: a report of 11 cases
Q87910600Hemophagocytic Syndrome Induced by HIV
Q36269994Hemophagocytic lymphohistiocytosis
Q38061236Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options
Q38749849Hemophilia in Iran.
Q33337683Hemostasis and Thrombosis: Clinical Usefulness of Combined use of Platelet Aggregation Test and Anti PF4-H. Antibodies Elisa test for the Diagnosis of Heparin Induced Thrombocytopenia
Q36746455Hemostatic changes in thyroid diseases: haemostasis and thrombosis
Q87912104Heparin Induces Apoptosis in Lymphocytes from B-cell Chronic Lymphocytic Leukemia
Q33371422Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation
Q33380753Heparin induced thrombocytopenia with thrombosis: a two step process?
Q39293427Hepatitis B reactivation in patients receiving targeted therapies
Q42952349Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies
Q87876333Hepatosplenic Candidiasis, its Treatment and Effect on Remission Status in Patients with Acute Leukaemia-a Report of Five Cases
Q36069473Hepcidin and cytokines in anaemia
Q46965468Hepcidin expression from monocyte of splenectomized and non-splenectomized patients with HbE-β-thalassemia
Q47684174Hereditary Red Cell Membrane Disorders in Japan: Their Genotypic and Phenotypic Features in 1014 Cases Studied
Q47683800Hereditary Thrombophilic Disease Associated with Defects in the Protein C Anticoagulant System
Q36416003Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview.
Q80376751Hereditary hemochromatosis
Q86536383Hereditary hemochromatosis
Q102203771Hereditary spherocytosis overlooked for 7 years in a pediatric patient with β-thalassemia trait and novel compound heterozygous mutations of SPTA1 gene
Q87910585Herpesvirus Infection in Patients Following Bone Marrow Transplantation: Influence of Viral Reactivation on Prognosis
Q33410603Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation.
Q33433886High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma
Q48347302High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis
Q40559541High expression of Midkine (MK) indicates poor prognosis in childhood acute lymphoblastic leukemia
Q45149702High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden
Q37107428High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies.
Q60339416High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma
Q38866790Histiocytosis disorders in Northeast Egypt: epidemiology and survival studies (a 5-year study).
Q73795176Hodgkin's disease variant of Richter's syndrome: complete remission of the both malignancies after 14 years
Q84925674Homing and engraftment of bone marrow cells derived from different donors in a murine model of sensitization
Q35994823Homoharringtonine: a new treatment option for myeloid leukemia
Q48286519Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin
Q126265060Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells
Q36270130How can hematopoietic cell transplant centers and referring physicians help each other during long-term follow-up?
Q33367294Human T-lymphotropic virus type I infection and idiopathic thrombocytopnic purpura
Q53721867Human platelet antigen 1, 2 and 5 gene polymorphisms in Egyptians and their potential association with susceptibility to immune thrombocytopenic purpura in Egyptian patients.
Q34879042Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells
Q54242690Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination.
Q61913883Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron
Q51742765Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports.
Q87901911Hydroxyurea is Worth a Trial in the Treatment of Patients with MDS with Myeloproliferative Features
Q74000754Hypercalcemia after High-Dose Chemoradiotherapy for Refractory Multiple Myeloma; Subject Heading
Q38897888Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature
Q59358534Hyperferritinemia: causes and significance in a general hospital
Q50794125Hyperhaemolysis syndrome in a patient with myelofibrosis.
Q104470386Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia
Q36761720Hyposplenism: a comprehensive review. Part I: basic concepts and causes
Q36799619Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and management
Q41083935IL-10-592 A/C polymorphisms is associated with EBV-HLH in Chinese children
Q41073890IL1α and TNFα Induction of Monocyte Chemoattractant Protein-1 (MCP-1/JE) in Bone Marrow Stromal Cells: The Role of Protein Kinase C (PKC) and Protein Tyrosine Kinase (PTK) Activity
Q53710223ISH 2014 World Congress: report of the Chair of Council.
Q88165725ISH Newsletter
Q91628679ISH Newsletter
Q87173901ISH initiatives for global hematology education and potential opportunities for sponsorships
Q50244445Identification and molecular characterization of a novel 163 kb deletion: The Italian (ϵγδβ)(0)-thalassemia.
Q47327031Identification of Hb Q-India (alpha64 Asp-->His) in Thailand
Q53773523Identification of Patients with Storage Pool Deficiency Using ATP Release and Dense Granule Counts.
Q47445409Identification of a de novo ANK1 mutation in a Chinese family with hereditary spherocytosis
Q98285362Identification of latent core genes and pathways associated with myelodysplastic syndromes based on integrated bioinformatics analysis
Q38342048Identification of new markers discriminating between myeloid and lymphoid acute leukemia
Q93253523Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia
Q38199534Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression
Q33430236Identifying the characteristics, natural behavioral pattern, and response to therapy in ITP in a multi-center population in Sri Lanka
Q33380751Idiopathic thrombocytopenic purpura in childhood: a 10-year audit
Q47683117Idiotypic Immune Targeting of Multiple Myeloma
Q50676897IgA anti-red blood cell auto-antibodies in Evans syndrome.
Q99205177IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases
Q87911029IgM Myeloma: An IgM Gammopathy Distinct from Waldenstrom's Macroglobulinemia
Q47683128Imaging Multidrug Resistance in Hematological Malignancies
Q44440134Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias
Q39573963Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells
Q36761730Imatinib-induced immune hepatitis: case report and literature review
Q33411812Immature platelet fraction levels in a variety of bone marrow pathologies in South African HIV-positive patients with thrombocytopenia
Q33423312Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia.
Q47581984Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation
Q35994828Immune agranulocytosis and clarithromycin
Q50057993Immune dysregulation in primary immune thrombocytopenia patients.
Q35080319Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation
Q46364017Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection
Q87046416Immune thrombocytopenia
Q35994817Immune tolerance therapy in patients with acquired hemophilia
Q91964185Immunoglobulin D (IgD) and IgD receptor expression in diffuse large B-cell lymphoma
Q82835014Immunoglobulin free light chains: do they have a role in plasma cell leukemia?
Q34789270Immunohematological aspects of bone marrow transplantation
Q85493871Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD38-positive plasma cells
Q38640438Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD.
Q36270148Immunotherapeutic aspects of stem cell transplantation
Q46779190Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling
Q41008753Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma
Q51755925Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: prognostic implications.
Q43785416Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients.
Q95305436Impact of anemia on the outcomes of chronic phase chronic myeloid leukemia in TKI era
Q57253038Impact of anti‐oxidant status and apoptosis on the induction phase of chemotherapy in childhood acute lymphoblastic leukemia
Q36270126Impact of chronic GVHD on late complications after hematopoietic cell transplantation
Q38858532Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children
Q52747009Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation.
Q46793590Impact of excess weight and estrogen receptor gene polymorphisms on clinical course of homozygous beta thalassemia
Q89066560Impact of interleukin 6 promoter polymorphisms (-174 G > C, -572 G > C and -597 G > A) on plasma IL-6 levels and their influence on the development of DVT: a study from India
Q36270049Impact of molecular profiling and cytogenetics in acute lymphoblastic leukemia
Q40312709Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities
Q44647000Impact of serum adiponectin and leptin levels in acute leukemia
Q33435188Impact of serum immunoglobulins level and IL-18 promoter gene polymorphism among Egyptian patients with idiopathic thrombocytopenic purpura
Q50599578Impact of socioeconomic status on sexual maturation of Nigerian boys living with sickle cell anaemia.
Q42232106Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era.
Q51743060Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis.
Q35080326Impaired phagocyte antibacterial effector functions in beta-thalassemia: a likely factor in the increased susceptibility to bacterial infections
Q46753529Implication of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-3 (IL-3) in Children with Acute Myeloid Leukaemia (AML).
Q74000819Implication of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-3 (IL-3) in Children with Acute Myeloid Leukaemia (AML); Malignancy
Q93049928Improvement of the hematologic toxicities of ruxolitinib in patients with MPN-associated myelofibrosis using a combination of thalidomide, stanozolol and prednisone
Q38003016Improving treatment for patients with chronic lymphocytic leukemia
Q40628679In VitroCytotoxic Effects of Stabilizing Sugars within Human Intravenous Immunoglobulin Preparations against the Human Macrophage THP-1 Cell-line
Q85899341In pursuit of the graft-versus-myeloma effect: a single institution experience
Q36269975In search of the transfusion threshold
Q83903826In vitro biology of human hematopoietic stem and progenitor cells
Q54694441In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood.
Q44941953In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin
Q50146370Incidence of Fanconi anaemia in phenotypically normal aplastic anaemia patients in West Bengal.
Q44864941Incidence of anemia and effect of nutritional supplementation on women in rural and tribal populations of eastern and northeastern India
Q39676625Incidence of aplastic anemia in a defined subpopulation from Mexico City
Q45891572Incidence of internal tandem duplications and D835 mutations of FLT3 gene in chronic myeloid leukemia patients from Southern India
Q51730820Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis.
Q46162832Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia
Q95646498Increased circulating basic fibroblast growth factor levels in acute myeloid leukemia: a meta-analysis
Q53122379Increased expression of HERG K+ channels contributes to myelodysplastic syndrome progression and displays correlation with prognosis stratification.
Q53381589Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma.
Q38747439Increased regulatory T cells in acute lymphoblastic leukaemia patients
Q38539663Increased regulatory T cells in acute lymphoblastic leukemia patients
Q55042855Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?
Q44941744Increments in circulating homocysteine before and after coronary artery bypass surgery in diabetic and non-diabetic patients
Q87878299Indications for and Value of Bone Marrow Trephine Biopsy in Haematological Disorders
Q53122380Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia.
Q47684293Induction of Apoptosis in Human Leukaemia Cells is Differentially Regulated by Vitamin D Derivatives and Retinoids
Q87879342Induction of Erythropoiesis by MHC-Mediated Cognate Interactions between B- and T-Cells
Q80454253Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia
Q74816951Infectious mononucleosis, peripheral blood. Hematology morphology forum
Q91315088Inflammation in deep vein thrombosis: a therapeutic target?
Q39950750Influence of Epstein-Barr virus infection in adult T-cell leukemia
Q83979163Influence of Helicobacter pylori infection associated with iron deficiency anaemia on growth in pre-adolescent children
Q50482880Influence of age on the correlations of hematological and biochemical variables with the stability of erythrocyte membrane in relation to sodium dodecyl sulfate.
Q35080323Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors
Q46374569Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors
Q74000712Infusional 5-fluorouracil in Cutaneous Leukaemia: a Novel Palliative Therapy in Haematological Malignancy; Malignancy
Q38556035Inherited bone marrow failure syndromes
Q36868584Inherited factor XI deficiency: a concise review
Q33423706Inherited thrombocytopenias.
Q83903810Inherited thrombophilic conditions
Q43434378Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells
Q38722874Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells.
Q90081304Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China
Q46504842Innovative PCR without DNA extraction for African sickle cell disease diagnosis.
Q87912385Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34(+) Cells in Multiple Myeloma Patients
Q38471219Integrating GO and KEGG terms to characterize and predict acute myeloid leukemia-related genes
Q87878280Intensified Induction and Post-Remission Therapy for Acute Myeloid Leukaemia
Q52552734Interaction between Hb E and Hb Yala (HBB:c.129delT); a novel frameshift beta globin gene mutation, resulting in Hemoglobin E/β0 thalassemia.
Q92263772Interactions of unstable hemoglobin Rush with thalassemia and hemoglobin E result in thalassemia intermedia
Q43632085Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma
Q53245753Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro.
Q87912099Interleukin 4 (IL4), IL10 and IL13 Inhibit in vitro Cytokine Secretion by Acute Myelogenous Leukemia Blasts in the Presence of Exogenous Hematopoietic Growth Factors
Q41073895Interleukin-11 Gene Expression in Human Lymphoid Malignancy
Q87879048Interleukin-11: Its Characterization and Physiological Effects
Q40874242Interleukin-3: Promises and Perspectives
Q39337514Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection
Q90590809International sentinel site surveillance of patients with transfusional hemosiderosis treated with deferasirox in actual practice setting
Q42878314Interstitial insertion of RARα gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17).
Q33374583Interstitial lung disease (ILD) and severe ITP.
Q87911785Intestinal Iron Transport and its Regulation
Q87911039Intraerythrocytic Iron Chelation: A New Therapy for Thalassemia?
Q92453162Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia
Q50749821Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood.
Q46523649Introduction of new formulas and evaluation of the previous red blood cell indices and formulas in the differentiation between beta thalassemia trait and iron deficiency anemia in the Makkah region
Q51465317Introduction of novel α1-hemoglobin gene mutation with transfusion-dependent phenotype.
Q36270101Introduction--the global problem of nutritional anemias
Q47622124Introductory Commentary on Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hematopoietic Stem Cells Ploemacher R. Et Al.
Q47618479Introductory Commentary on Regulation of LFA-1 Expression by CD34+ Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments, Torensma et al.
Q47622097Introductory Commentary on The Role of Stromal Integrin Interactions in Pro-B-Cell Proliferation Hahn et al.
Q52771944Inverse relationship between vitamin D levels and platelet indices in Korean adults.
Q40418741Investigation of T-cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) polymorphisms in essential thrombocythaemia (ET).
Q33369164Investigation of persistent hypochromic microcytosis unmasks hemoglobin Evanston [alpha 14 (A12) Try--> Arg] in a patient of cyclic thrombocytopenia preceding Takayasu's disease
Q33435991Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia
Q48049196Investigation of the differences between the Tibetan and Han populations in the hemoglobin-oxygen affinity of red blood cells and in the adaptation to high-altitude environments.
Q92437769Investigation on glucocorticoid receptors within platelets from adult patients with immune thrombocytopenia
Q52134106Involvement of E-cadherin in the Development of Erythroid Cells; Subject Heading.
Q39843818Involvement of Rap-1 activation and early termination of immune synapse in CTLA-4-mediated negative signal
Q47396530Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK(+) anaplastic large cell lymphoma
Q85493882Iranian experience of deferasirox (Exjade(®)) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels?
Q54403775Iron Deficiency Anemia Associated with an Error of Iron Metabolism in Two Siblings: A Thirty Year Follow Up.
Q87901921Iron Deficiency Developing in Patients with Homozygous Hypercholesterolaemia on Long-term Plasmapheresis is Significantly Contributed to by Extracorporeal Haemolysis
Q50623726Iron deficiency anaemia and evaluation of the utility of iron deficiency indicators among healthy Nigerian children.
Q85712294Iron deficiency anemia
Q52594556Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care.
Q28219478Iron deficiency in childhood and adolescence: retrospective review
Q50711417Iron deficiency screening in the first three years of life: a three-decade-long retrospective case study.
Q36270045Iron overload and chelation
Q38476053Iron overload in transfusion-dependent thalassemia
Q45753026Iron-chelation therapy with oral chelators in patients with thalassemia major
Q45804415Is Friday leukemia a non-entity?
Q47684140Is Granulocyte Colony-stimulating Factor Safe in the Treatment of Febrile Neutropenia in Lymphoma Patients with Renal Transplantation?
Q86243271Is Pica under-reported in children with sickle cell disease? A pilot study in a Belgian cohort
Q81409263Is assessment of surface CD38 expression worthwhile as a prognostic factor in chronic lymphocytic leukemia patients?
Q39343047Is intensive monitoring during the first transfusion in pediatric patients necessary?
Q48108637Is obstructive sleep apnoea syndrome really one of the causes of secondary polycythaemia?
Q63241090Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?
Q47206772Is there a difference in phenotype between males and females with non-transfusion-dependent thalassemia? A cross-sectional evaluation
Q35022123Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma?
Q36746459Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
Q81243482Isolated central nervous system relapse during cytologic and molecular hematologic remission in two patients with acute promyelocytic leukemia
Q50452332Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells.
Q34637546JAK2 inhibitors and their impact in myeloproliferative neoplasms
Q39162818JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.
Q83926743Jaundice and alpha gene triplication in beta-thalassemia: association or causation?
Q81271196Juvenile myelomonocytic leukemia
Q54649935KDR and Sema3 genes expression in bone marrow stromal cells and hematopoietic cells from leukemia patients and normal individuals.
Q40212266Kidney injury in infants and children with iron-deficiency anemia before and after iron treatment
Q44440140Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures
Q87878037Kleihauer Testing and Flow Cytometry. A Comparative Study for Assessment of Feto-Maternal Haemorrhage
Q47666357Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway
Q44108314L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome
Q51790001Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes.
Q44688146Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers
Q87979306Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre
Q74000719Late Effects of Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation
Q87879796Late Relapse After Allogeneic Bone Marrow Transplant In a Patient With Myelodysplasia
Q36270122Late effects of hematopoietic stem cell transplantation
Q37791617Lenalidomide: a synthetic compound with an evolving role in cancer management
Q87879354Leucocyte Immunophenotyping: The Need for Standardization
Q79358880Leukemia associated clonal expansion of TCR Vbeta subfamily T cells
Q37212366Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL).
Q39939249Ligation of CD44 leads to killing activity in human peripheral mononuclear cells via MAP kinase and tyrosine kinases
Q39820261Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line
Q46156541Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden
Q46590378Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children
Q92144057LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells
Q104682091Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia
Q91145654Long non-coding RNAs MALAT1, MIAT and ANRIL gene expression profiles in beta-thalassemia patients: a cross-sectional analysis
Q42714159Long term curative effects of sequential therapy with all-trans retinoic acid, arsenious oxide and chemotherapy on patients with acute promyelocytic leukemia
Q43934706Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload
Q46490988Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major.
Q84349986Long-term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country
Q90590794Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan
Q48503097Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients.
Q51460184Low oxygen saturation and severe anemia in compound heterozygous Hb Louisville [β42(CD1)Phe→Leu] and Hb La Desirade [β129(H7)Ala→Val].
Q38990530Low turnover bone disease in Egyptian children with acute leukemia
Q51795374Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma.
Q33406040Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases
Q33413790Low-dose rituximab in the treatment of acquired haemophilia
Q33431511Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP.
Q44703351Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia
Q33373655Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major
Q86979692Lymphoid neoplasms
Q42979416Lymphomas and leukemias due to infectious organisms
Q44544162MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma
Q48506102MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture.
Q47684280Macrophage Inflammatory Protein-1 Alpha: A Paradox?
Q46600569Macrophages promote development of human erythroid precursors in transferrin-free culture medium
Q40714865Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma
Q87896680Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma
Q33343830Major histocompatibility complex susceptibility genes and immune thrombocytopenic purpura in Caucasian adults
Q33401582Malaria: a haematological disease
Q101453994Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center
Q74000565Malignancy: 2'-Chlorodeoxyadenosine Effectively Induces Complete Remission in Hairy Cell Leukaemia
Q74000450Malignancy: A New Approach to the Analysis of Apoptosis in the Leukemic Subpopulation by Flow Cytometry Using a CD45 Gating Strategy
Q74000605Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease
Q74000571Malignancy: Case Report: Acute Promyelocytic Leukemia in Late Pregnancy. Successful Treatment with All-Trans-Retinoic Acid (ATRA) and Chemotherapy
Q34278254Malignancy: Case Report: Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature
Q34278245Malignancy: Case Report: Muscle Involvement in Multiple Myeloma: Report of a Patient Presenting Clinically as Polymyositis
Q34278260Malignancy: Case report: Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine.
Q74000660Malignancy: Changes in Circulating Immature and Mature Dendritic Cells During IL-2 Cancer Immunotherapy and Their Relation with Lymphocyte Increase and Clinical Response
Q74000445Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic Syndromes
Q74000512Malignancy: Current Clinical Practice: Treatment of Hairy Cell Leukemia at the Close of the 20th Century
Q34278291Malignancy: Gene Therapy Vaccines in Acute Myeloid Leukemia : A Need for Clinical Evaluation
Q40601458Malignancy: Granulocyte Colony Stimulating Factor Increases the Efficacy of Conventional Amphotericin in the Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients following Intensive Chemotherapy or Bone Marrow Transplantation f
Q45736983Malignancy: Human T-Cell Lymphotropic Virus Type I and Adult T-Cell Leukaemia/Lymphoma
Q74000643Malignancy: Identification of Predictors of Disease Status and Progression in Patients with Myeloma (MM)
Q74000601Malignancy: Idiotypic Immune Targeting of Multiple Myeloma
Q74000482Malignancy: Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34+ Cells in Multiple Myeloma Patients
Q34278277Malignancy: Meningeal Myeloma: A Case Report and Review of Literature
Q55034869Malignancy: Molecular Demonstration of BCR/ABL Fusion in a Patient with Chronic Myelogenous Leukemia with Basophilia Carrying a Variant t(16;22) (q24;q11) Philadelphia Chromosome.
Q74000636Malignancy: Myeloma - the Elusive Cure
Q74000418Malignancy: Subsequential Alterations of Telomeric DNA Length Correlate with Cytogenetic Response in Chronic Myeloid Leukemia Treated with Interferon alpha
Q74000490Malignancy: The Number of Nucleoli and Main Nucleolar Types in Lymphoblasts of Children Suffering from Acute Lymphoid Leukemia
Q34278271Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia
Q44485225Malignancy: X-Linked Cytochrome B Positive Chronic Granulomatous Disease treated by Bone Marrow Transplantation
Q74000665MalignancyCase Report: Systemic Sarcoidosis Preceeding Acute Myeloid Leukemia
Q53745563Management of Aplasia.
Q30843420Management of Hodgkin's lymphoma with midbrain involvement: A case report and review of literature
Q28167261Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillation
Q36194564Management of bleeding in the terminally ill patient
Q36270118Management of invasive fungal infections in neutropenic patients
Q54278466Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part I. Chronic Lymphocytic Leukemias.
Q38894184Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part II: Chronic Granulocytic Leukemia
Q34780619Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias
Q37372868Management of transfusional iron overload in Latin America: current outlook and expert panel recommendations
Q82653401Manual and automated reticulocyte counts
Q53759833Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera.
Q80454226Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia
Q81203958Massive deep venous thrombosis and venous gangrene in a 29-year-old case: metastatic epidermoid carcinoma with an unknown primary
Q41584606Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México
Q57806533Maternal sickle cell disease and twin pregnancy: a case series and review of the literature
Q47624319Matrix Metalloproteinases
Q47683108Matrix Metalloproteinases in the Hematopoietic Microenvironment
Q33433839Mean Platelet Volume in Thrombocytopenic, Preterm Infants
Q88315285Mean platelet volume at baseline and immune thrombocytopenia relapse in Chinese newly-diagnosed patients: a retrospective cohort study
Q80559452Mean platelet volume measurement, EDTA or citrate?
Q46150811Measurement of Th1, Th2 cytokines and white cell count in childhood haemoglobinopathies with uncomplicated malaria infection
Q40081650Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells
Q40799496Megakaryocytic Maturation is Regulated by Maintaining a Balance Against Cytokine Induced-cell Proliferation: Steel Factor Retards Thrombopoietin-induced Megakaryocytic Differentiation While Synergistically Stimulating Mitogenesis; Hematopoiesis
Q85900597Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a
Q36270106Megaloblastic Anaemia (MA).
Q46570611Meningioma 1 (MN1) expression: refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML).
Q46214607Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia
Q53161925Meta-analysis on effectiveness of hydroxyurea to treat transfusion-dependent beta-thalassemia.
Q53785420Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSF.
Q48175363Methionine synthase reductase deficiency (CblE): A report of two patients and a novel mutation.
Q44354498Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico
Q54266084Methylation status of CEBPA gene promoter in chronic myeloid leukemia.
Q39337531Methylprednisolone induces apoptosis by interacting with the JAK/STAT pathway in HL-60 and K-562 leukemic cells
Q54515813Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.
Q38954464MicroRNA-21 is involved in X-ray irradiation resistance in K562 leukaemia cells
Q38015971MicroRNAs in hematological malignancies: a novel approach to targeted therapy
Q87879800Microangiopathic Hemolytic Anemia Associated with the use of both Cyclosporin A and FK506 (Tacrolimus) in the Same Patient
Q39448190Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics
Q83903754Minimal disease detection of B-cell lymphoproliferative disorders by flow cytometry: multidimensional cluster analysis
Q57788892Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission
Q91536117Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia
Q91964255Minimal residual disease may be an early prognostic indicator for newly diagnosed acute myeloid leukemia patients induced by decitabine-based chemotherapy
Q89547246Mitochondrial ferritin expression in erythroid cells from patients with alpha-thalassaemia
Q45753490Mitral valve surgery in severe congenital factor VII deficiency
Q46175818Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
Q50761044Modeling for tertiary structure of globin chain in Hemoglobin Suan-Dok disorder.
Q39608150Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation.
Q39851542Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia
Q37618337Modern concepts in the treatment of chronic lymphocytic leukemia
Q46490986Modified IDARAM chemotherapy regimen for primary central nervous system lymphoma: experience of three cases
Q52723326Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease.
Q38894494Modulation of Platelet Aggregation Response by Factors Released from Polymorphonuclear Leukocytes
Q47330431Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts.
Q58001051Molecular Cytogenetic Analysis of B-CLL Patients with Aggressive Disease
Q44932470Molecular Medicine and Molecular Pathology for Haematologists: I. Gene Speak made Easy: An Overview of Genes and Gene Expression
Q74000458Molecular Medicine and Molecular Pathology for Hematologists: II. Lets go Techno; Principles of the Molecular Technologies and their Applications in Haematology
Q38894040Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria
Q87911409Molecular Pathology of Thalassemia and Triplicated Locus in North Indian Population; Interaction with Heterozygous Thalassemia
Q47976021Molecular analysis of abnormal hemoglobins in beta chain in Aegean region of Turkey and first reports of hemoglobin Andrew-Minneapolis and Hb Hinsdale from Turkey
Q87328708Molecular analysis of patients with severe congenital factor X deficiency: First report from north and northwest of Iran
Q37183513Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia
Q38952102Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy
Q37737808Molecular basis of hereditary iron homeostasis defects
Q35022121Molecular biology of gastric MALT lymphoma: application in clinical management
Q38003013Molecular biology strategies to detect residual disease
Q62583488Molecular characterization of chronic myeloproliferative neoplasias in México
Q45961847Molecular diagnosis and prognosis with DNA microarrays.
Q83903734Molecular genetics of acute myeloid leukemia: clinical implications and opportunities for integrating genomics into clinical practice
Q35670986Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis
Q83926729Molecular immunoglobulin/T-cell receptor clonality diagnosis by gene scan in lymphoproliferative disorders
Q35197150Molecular markers in myeloproliferative disorders: from classification to prognosis?
Q38074249Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia
Q35668677Molecular monitoring of minimal residual disease in patients with multiple myeloma
Q54566418Molecular pathogenesis and clinical variability of homozygous beta0-thalassemia in populations of Jammu region of J&K state (India).
Q38003012Molecular targeted therapy in acute myeloid leukemia
Q84753703Molecular variants and clinical importance of beta-thalassaemia traits found in the state of Orissa, India
Q50052828Mometasone furoate inhibits growth of acute leukemia cells in childhood by regulating PI3K signaling pathway.
Q35080331Monitoring of low molecular weight heparin in pregnancy
Q40184741Monoclonal B-cell lymphocytosis in blood donors in Turkey
Q83903745Monoclonal antibodies in adult acute lymphoblastic leukemia
Q33400764Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
Q38896604Monocyte and Haemostasis
Q53544513Monocytosis is associated with hemolysis in sickle cell disease.
Q33430243More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.
Q33437618More on the thrombocytopenia of the non-alcoholic fatty liver disease
Q39355501Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo Antisense in BCR-ABL(+) cells
Q36270054Morphology in the diagnosis of red cell disorders
Q36074388Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug Development
Q47327051Mu-heavy chain disease associated with systemic amyloidosis
Q87926784Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis
Q40081644Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells
Q87912108Multiple Myeloma Presenting with Crystal Deposition in the Bone Marrow
Q46600575Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome
Q86561572Multiple myeloma
Q44354524Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model
Q83903699Multiple myeloma: treatment evolution
Q36687989Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report
Q41923461Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis
Q91628708Multivariate logistic analysis of predictors of response to immunosuppressive therapy in children with aplastic anemia: a double-center study
Q96021437Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation
Q74597212Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis
Q41698364Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis
Q85712299Myelodysplasia
Q38897894Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine
Q33345617Myelodysplasia and the acute myeloid leukaemias
Q33376659Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature
Q43727366Myelodysplastic syndromes: classification and prognostic scoring systems and their applicability in Indian scenario-experience from a tertiary care center
Q87417742Myelofibrosis
Q50676888Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin's lymphoma who underwent autologous hematopoietic stem cell transplantation.
Q87896685Myeloid Leukemia After Cytotoxic Therapy and Other Hematotoxins
Q47625068Myeloma Presenting in the Base of the Skull
Q46272130Myeloma Presenting with Massive Splenomegaly
Q81271143Myeloma bone disease
Q48452296Myeloma: diagnosis complications and supportive care.
Q74000559Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera
Q53324816Myeloproliferative Disease: Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass.
Q96612056Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting
Q50462408Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
Q98387827Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis
Q53270482NK-cell neoplasms in Japan.
Q44959828NPM1, FLT3-ITD, CEBPA, and c-kit mutations in 312 Chinese patients with de novo acute myeloid leukemia
Q37383687Near-infrared spectra absorbance of blood from sickle cell patients and normal individuals
Q46374593Nephrotic syndrome associated with chronic lymphocytic leukaemia
Q46929634Neurocognitive dysfunction in children with β thalassemia major: psychometric, neurophysiologic and radiologic evaluation.
Q82754988Neurofibromatosis type I and smoldering multiple myeloma: a case report
Q74000748Neurosarcoidosis Associated with Hodgkin's Disease; Malignancy
Q36828921Neutropenia and G-CSF in lymphoproliferative diseases
Q28203932Neutrophil elastase mutations in congenital neutropenia
Q58134897New ISH website
Q91628717New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways
Q36270022New development in anticoagulant and antithrombotic therapy: are we on the right track?
Q83903778New developments in the field of diffuse large cell lymphoma
Q38003014New developments in the management of diffuse large B-cell lymphoma
Q81243535New insights into paroxysmal nocturnal hemoglobinuria
Q30929503New strategies for BMT, organ transplantation, and regeneration therapy
Q43173262Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts
Q50665720Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome.
Q74000793Nitric Oxide Metabolites in Sickle Cell Anemia Patients after Oral Administration of Hydroxyurea; Hemoglobinopathy
Q33382856Nitric oxide in immune thrombocytopenic purpura
Q53810729Nitrite and Nitrate Plasma Levels, as Markers for Nitric Oxide Synthesis, in Thrombotic Thrombocytopenic Purpura (TTP).
Q44108317No cytomegalovirus-related deaths after non-ablative stem cell allografts
Q87876335Nocardiosis Causing Hypocellular Bone Marrow after Allogeneic Peripheral Blood Stem Cell Transplantation
Q87912111Non-inpatient Treatment of Febrile Episodes in Patients with Hematological Malignancy
Q63241096Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience
Q39379442Non-pharmacologic management of sickle cell pain
Q84349974Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemia
Q93216314Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography
Q59629334Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors
Q104138612Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B
Q93349043Notice of Duplicate Publication
Q52867582Novel Haematological Parameters in Patients Receiving Recombinant Human Erythropoietin and Undergoing Haemodialysis.
Q49849870Novel interactions of two α-Hb variants with SEA deletion α(0)-thalassemia: hematological and molecular analyses.
Q51747462Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I.
Q83903737Novel therapeutic strategies for AML in 2012
Q34637538Novel therapeutics in multiple myeloma
Q38003015Novel therapies in monoclonal gammopathies
Q57904916Novel treatments of multiple myeloma
Q39015645Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.
Q39004780Number of parity and the risk of non-Hodgkin lymphomas: a dose-response meta-analysis of observational studies
Q38746865Nutritional status in children and adolescents with leukemia: An emphasis on clinical outcomes in low and middle income countries
Q48336293Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece
Q89293152Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia
Q53176650Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Q33371425Onset of severe refractory thrombocytopenia following surgery in a patient with type 2B von Willebrand disease--a case report
Q45886996Optimal length of time of cryopreserved umbilical cord blood infusion after thawing
Q39979643Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials
Q87878285Optimising Treatment for Elderly Patients with Acute Leukaemia
Q36270110Optimizing clotting factor replacement therapy in hemophilia: a global need
Q35173183Oral mucositis: time for more studies
Q52180946Osteoblasts and The Hematopoietic Microenvironment.
Q47624307Osteogenesis and The Microenvironment.
Q37212358Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature
Q35126992Outcome and toxicity of salvage treatment on patients relapsing after autologous hematopoietic stem cell transplantation--experience from a single center.
Q50873125Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey.
Q39510856Outcome of childhood acute Lymphoblastic leukemia in Egyptian children: a challenge for limited health resource countries.
Q36939568Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature
Q43554766Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia
Q92424209Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution
Q43258162Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis
Q42511622Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Q46900406Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model.
Q87879614Owen Stuart Roath (1929-1997)
Q46214480Oxidative crosslinking, spectrin and membrane interactions of hemoglobin mixtures in HbEbeta-thalassemia
Q46429946Oxidative process in erythrocytes of individuals with hemoglobin S.
Q38861109Oxidative stress in erythrocytes of banked ABO blood
Q90235401Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children
Q87912909P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival
Q74000805P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival; Malignancy
Q46979570P-glycoprotein (P-170) expression in acute leukemias
Q89372545PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model
Q87878296Parenteral Iron and Recombinant Human Erythropoietin Therapy to Stimulate Erythropoiesis in Patients Undergoing Repair of Hip Fracture
Q50711129Parvovirus B-19 induced acute pure red cell aplasia in patients with chronic lymphocytic leukemia and neurofibromatosis type-1.
Q39621941Parvovirus B19 infection in children with a variety of hematological disorders
Q46241407Parvovirus and herpes simplex association with unexplained anemia in pregnancy: a prospective study
Q45856316Pathogenesis and Management of Acquired Haemophilia
Q87903091Pathogenesis of Autoimmune Diseases in Large Granular Lymphocyte Leukemia
Q87899096Pathogenesis of Hyperhomocysteinemia-New Insights
Q38896695Pathogenesis of Idiopathic Myelofibrosis: A Review
Q87878025Pathogenesis of Thrombotic Complications of Haematological Malignancies
Q91964196Pathogenesis of aplastic anemia
Q41073900Pathogenetic Aspects of Myelodysplastic Syndromes
Q47201190Pathogenicity analysis of variations and prenatal diagnosis in a hereditary coagulation factor XIII deficiency family
Q36328383Patient understanding of warfarin therapy: a review of education strategies
Q86625862Patient-specific microRNA expression profiles as a marker for minimal residual disease in acute myeloid leukemia
Q45866290Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran
Q87426774Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia
Q38855966Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience
Q28248388Pearson syndrome in an infant heterozygous for C282Y allele of HFE gene
Q91162536Pediatric mature B-cell NHL, early referral and supportive care problems in a developing country
Q40702666Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; Malignancy
Q53133828Peripheral and bone marrow CD34+ cell levels on chronic myeloproliferative disease.
Q79358887Persistent questions about the treatment of severe aplastic anemia in children as illustrated by five cases
Q40484494Persistent splenomegaly in an adult female with homozygous sickle cell anemia.
Q74816930Peyronie's disease as a complication of chronic graft versus host disease
Q34327594Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies
Q92090644Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency
Q35809469Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors
Q58148282Phenotype and TCR-gamma gene rearrangements in a Malaysian cohort of T-cell leukaemia/lymphoma cases
Q47624329Phenotypic and Functional Characterization of Human Marrow Vascular Stromal Cells
Q113848426Phenotypic and genetic analyses of four cases of coagulation factor XII deficiency
Q50893727Phenotypic and genetic analysis of dysprothrombinemia due to a novel homozygous mutation.
Q33369158Philadelphia chromosome positive acute lymphoblastic leukemia showing normal karyotype in G-banding chromosomal examination before chemotherapy
Q38635161Philadelphia chromosome-positive Acute Lymphoblastic Leukemia
Q46374584Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome
Q47328529Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Q47683143Phosphorylation of the Retinoblastoma Protein in Childhood Acute Lymphoblastic Leukemia
Q89785365Physical exercise is safe and feasible in thrombocytopenic patients with hematologic malignancies: a narrative review
Q38042778Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia
Q38003010Planetary change and biochemical adaptation: molecular evolution of corrinoid and heme biosyntheses.
Q30640505Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Q50505015Plasma Proteins Case Report: Massive Bone Marrow Necrosis with Polyclonal Hypergammaglobulinemia and Blue Toe Syndrome.
Q84299401Plasma cell leukemia--a study of 28 cases from India
Q91354543Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma
Q44765608Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea
Q46844319Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state
Q53705061Platelet Activation in Hypercholesterolemic Patients Submitted to Therapeutic Plasmapheresis. An Ultrastructural Study.
Q33403314Platelet count and serum thrombopoietin level as predictors for morbidity and/or mortality in thrombocytopenic neonates
Q33349456Platelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis
Q33358034Platelet counts and interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher disease
Q84925680Platelet distribution width as an indicator of microvascular complications in type 2 diabetic patients
Q33432087Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk
Q36270009Platelet function testing in cardiovascular diseases
Q46556370Platelet function testing in uraemic patients
Q83649605Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications
Q36270004Platelets in sepsis
Q45038109Ploidy Analysis and Ki-67 Expression in Myelodysplastic Syndromes
Q87903565Point of Care Testing in Haematology
Q87046419Polycythaemia vera
Q54141441Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass.
Q41178645Polymorphic variants of GSTM1, GSTT1, and GSTP1 genes in childhood acute leukemias: A preliminary study in Argentina
Q57176443Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia A
Q39145866Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells
Q48328481Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma
Q89459888Possible association of 3' UTR +357 A>G, IVS11-nt 93 T>C, c.1311 C>T polymorphism with G6PD deficiency
Q87879358Post Chernobyl Hemoblastoses in the Republic of Belarus (brief communication)
Q79964247Post-gastrectomy anemia: evaluation of 72 cases with post-gastrectomy anemia
Q38756198Post-therapeutic recovery of serum interleukin-35 level might predict positive response to immunosuppressive therapy in pediatric aplastic anemia
Q40232543Potential over request in anemia laboratory tests in primary care in Spain.
Q90175424Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients
Q48114774Pre-transplantation thymic function is associated with the risk of acute graft versus host disease and cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.
Q46429951Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia
Q88922136Predictive factors of daily opioid use and quality of life in adults with sickle cell disease
Q40439520Predictive factors of septic shock and mortality in neutropenic patients
Q47413364Predictive parameters for imatinib failure in patients with chronic myeloid leukemia.
Q43173266Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation
Q41578520Predictive value of F-18 FDG PET/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma
Q86802090Preeclampsia: are platelet count and indices useful for its prognostic?
Q35670982Pregnancy associated aplastic anemia--a series of 10 cases with review of literature
Q38570916Pregnancy in beta-thalassemia trait carriers: an uneventful journey
Q87940371Preliminary investigation about the expression of tubulin in platelets from patients with iron deficiency anemia and thrombocytosis
Q87879060Prenatal Diagnosis of β-Thalassemia Using Multiplex Allele-Specific Amplification (MASPCR) in Chinese Families
Q38194607Preoperative transfusion in patients with sickle cell disease to prevent perioperative complications: a systematic review and meta-analysis.
Q35605120Preparative therapies used for those with Fanconi's anemia undergoing stem cell transplants and subsequent engraftment rates
Q88393101Pretransplant serum FT3 levels in recipients predict early non-relapse mortality after myeloablative allogeneic haematopoietic cell transplantation from matched sibling donors
Q104566998Pretreatment grade 4 thrombocytopenia is an independent prognostic factor in adult acute lymphoblastic leukemia: an extended analysis of a single-center retrospective study
Q53164864Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia.
Q93385627Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias
Q31111317Prevalence and cumulative 5-year incidence of chronic lymphocytic leukemia in the adult population in the Russian Federation and Ukraine: Data from the LEUKOSPECT study.
Q41467048Prevalence of hemoglobin E in Yunnan Province of Southwest China
Q51945410Prevalence of iron deficiency anemia among adolescent schoolgirls from Kermanshah, Western Iran.
Q50108312Prevalence of iron deficiency in a total joint surgery population.
Q87876338Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa
Q86188033Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A
Q54107223Primary Hyperparathyroidism and Lymphoproliferative Diseases: Three Case Reports.
Q38096667Primary bone marrow T-cell/histiocyte-rich large B-cell lymphoma: a diagnostic challenge
Q24646477Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy
Q81450829Primary duodenal diffuse large cell non-hodgkin lymphoma with involvement of ampulla of Vater: report of 3 cases
Q81243527Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure
Q40492477Primary myelodysplastic syndrome in children--clinical, hematological and histomorphological profile from a tertiary care centre in India
Q54266096Primary research on unrelated double umbilical cord blood transplantation and implantation kinetics.
Q81973609Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis
Q38457581Principles of the Polymerase Chain Reaction in Haematology
Q53528283Procoagulant factors in patients with cancer.
Q48118204Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation
Q38316906Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population
Q39447794Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt
Q39447801Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura, Egypt
Q104470364Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis
Q46737739Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors
Q102203754Prognostic factors for patients with multiple myeloma admitted to the intensive care unit
Q35197154Prognostic factors in adult acute lymphoblastic leukemia
Q47630011Prognostic factors in the survival of patients with blood disorders recovering from septic shock
Q49838769Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients.
Q39631733Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype
Q45900362Prognostic impact of serum 25-hydroxivitamin D [25(OH)D] concentrations in patients with lymphoid malignancies.
Q39450821Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia
Q89180620Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis
Q53164854Prognostic significance of HOXB4 in de novo acute myeloid leukemia.
Q58005555Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis
Q96612064Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas
Q39273693Prognostic significance of WT1 expression at diagnosis and end of induction in Egyptian adult acute myeloid leukemia patients
Q51759886Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma.
Q91058872Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis
Q104567066Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia
Q93092541Prognostic value of DNMT3A mutations in myelodysplastic syndromes: a meta-analysis
Q51055200Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP.
Q33375990Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review
Q50542130Proposal of a score combining red blood cell indices for early differentiation of beta-thalassemia minor from iron deficiency anemia.
Q87351689Proposed minimal panel of antibodies for cost-effectiveness and accuracy in acute leukemias immunophenotyping: Prospective study at a tertiary care center
Q36270134Prospects for developing a molecular cure for thalassemia
Q48214761Protector effect of α-thalassaemia on cholecystitis and cholecystectomy in sickle cell disease.
Q47683809Protein Turnover, Energy Expenditure and Body Composition in Patients with Acute Leukaemia Undergoing Chemotherapy
Q38043676Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review
Q36328401Protein palmitoylation in signal transduction of hematopoietic cells
Q40081656Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activity
Q46970334Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib
Q47348288Protein-protein interaction networks and different clustering analysis in Burkitt's lymphoma
Q90081262Proteomic tools and new insights for the study of B-cell precursor acute lymphoblastic leukemia
Q81243492Pseudo-Gaucher cells in Hb E disease and thalassemia intermedia
Q83979157Pseudobasophilia and the Advia 120
Q34234548Public health surveillance and data collection: general principles and impact on hemophilia care
Q41745150Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron
Q54215644Pulsatilla saponin A induces differentiation in acute myeloid leukemia in vitro.
Q45353058Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children
Q85900088Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis
Q87896939Pyruvate Kinase Deficiency which Causes Nonspherocytic Hemolytic Anemia: The Gene and its Mutations
Q86802957Quality of harvest and role of cell dose in unrelated bone marrow transplantation: an Italian Bone Marrow Donor Registry-Gruppo Italiano Trapianto di Midollo Osseo Study
Q87426777Quantitative assessment of BAX transcript and flow cytometric expression in acute myeloid leukemia: a prospective study
Q34780634Quantitative real-time PCR: a critique of method and practical considerations
Q38958499Quercetin alleviates myocyte toxic and sensitizes anti-leukemic effect of adriamycin
Q39477231Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells
Q50462438RBC alloimmunization and double alloantibodies in thalassemic patients.
Q93099780RETRACTED ARTICLE: Retraction
Q54982773RETRACTED: Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
Q39506861RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis
Q38778304ROS functions as an upstream trigger for autophagy to drive hematopoietic stem cell differentiation
Q28393778Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable?
Q44353403Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma
Q87910581Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy
Q39331020Rapid and inexpensive detection of common HBB gene mutations in Tunisian population by high-resolution melting analysis: implication for molecular diagnosis
Q43083995Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD).
Q80205146Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma
Q81243512Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report
Q36270085Rationales for therapeutic apheresis
Q91229171Re-personalization and stratification of hemophilia care in an evolving treatment landscape
Q44640583Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft
Q100951749Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries
Q40896319Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience
Q87911778Reasons to Eliminate Umbilical Cord Blood Units before Cryopreservation
Q38894371Recent Advances in Bone Marrow Transplantation from Unrelated Volunteer Donors.
Q36194575Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells
Q36221526Recent thymic output function in patients with hematological malignancy
Q45881838Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias
Q33365354Recombinant activated factor VII in patients at high risk of bleeding
Q45864633Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent
Q81243488Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation
Q42226584Recombinant human lipocalin 2 acts as an antibacterial agent to prevent platelet contamination.
Q47815810Recommendations on the use of ruxolitinib for the treatment of myelofibrosis
Q74816925Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation
Q53103287Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience.
Q44108320Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia
Q50594822Red blood cell flags for the differential diagnosis between thalassemia trait and iron deficiency anemia.
Q44446250Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India
Q44108310Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia
Q33397101Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim
Q46981708Reduced serum retinol-binding protein levels in patients with de novo acute myeloid leukaemia
Q87640404Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience
Q46761942Reference percentiles of hematological and biochemical iron values of blood donors in Port Harcourt, Nigeria
Q40643753Refractory Castleman's Disease
Q115041145Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab
Q40610270Regional Variations in the Further Management of Neutropenic Patients already Receiving Empirical Antimicrobial Therapy
Q36269959Regulation and dysregulation of hematopoiesis by a cytokine-induced antiapoptotic molecule anamorsin
Q40799492Regulation of LFA-1 Expression by CD34 Positive Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments; Subject Heading
Q89572138Regulatory T cells and CD20+ B cells in pediatric very severe aplastic anemia: possible clinical markers for evaluating the therapeutic efficacy and prognosis
Q38744187Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor
Q87899110Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis
Q38992024Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients
Q54570438Relationship Between Gestational Iron Deficiency and Iron Deficiency in the Newborn; Erythrocytes.
Q39099149Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms
Q54197606Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients.
Q36180564Relationship between cigarette smoking and risk of chronic myeloid leukaemia: a meta-analysis of epidemiological studies
Q33431514Relationship between expression of glucocorticoid receptor isoforms and glucocorticoid resistance in immune thrombocytopenia
Q43258160Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome
Q57283957Relationship between genetic polymorphism of MTHFR C677T and lower extremities deep venous thrombosis
Q43450491Relationship between maternal hemoglobin concentration and neonatal birth weight
Q47214705Relationship between obesity and iron deficiency anemia: is there a role of hepcidin?
Q57785626Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study
Q50555211Reliability of red blood cell indices and formulas to discriminate between beta thalassemia trait and iron deficiency in children.
Q46045843Renal function in adult Jamaicans with homozygous sickle cell disease
Q44648938Renal function in transfusion-dependent pediatric beta-thalassemia major patients
Q51746881Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment.
Q48301582Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine
Q38864887Research on the clinical effect and in vitro study of HLA-mismatched hematopoietic stem cell infusion for acute myeloid leukemia
Q54325932Respiratory Failure and Intensive Care Support Following Bone Marrow Transplantation.
Q88617853Response to letter: Wenle Zhao and Vance W. Berger, Better alternatives to permuted block randomization for clinical trials with unequal allocation
Q44083412Response to low-dose desmopressin by a subcutaneous route in children with type 1 von Willebrand disease
Q83304143Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients
Q87911781Results of a Controlled Clinical Trial Radiotherapy versus Combined Therapy in the Management of Stage IE Orbital Marginal Zone B-cell Lymphoma
Q33381495Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia
Q34329286Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest
Q43950281Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation
Q44543457Retrospective epidemiological study of Latin American patients with transfusional hemosiderosis: the first Latin American epidemiological study in iron overload--the RELATH study
Q47965123Reversal of Life-Threatening Vascular Occlusion by Apheresis in Fulminating Plasmodium Falciparum Malaria
Q35668684Reversal of MDR by verapamil analogues
Q39476898Reverse hybridization StripAssay detection of beta-thalassemia mutations in northeast Egypt.
Q45173516Reverse seroconversion of hepatitis B virus after allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease
Q38673817Revisiting beta thalassemia intermedia: past, present, and future prospects.
Q39090567Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53.
Q58470546Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: Retrospective analysis in a single institution
Q93385633Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study
Q51119875Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma.
Q58596828Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer
Q93042275Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients
Q40321913Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections
Q50759875Risky behaviours of Jamaican adolescents with sickle cell disease.
Q84299396Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders
Q33400762Rituximab in the treatment of TTP.
Q45327137Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung.
Q33364313Rituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura
Q37293515Rivaroxaban: future in anticoagulation practice?
Q87879604Role of Soluble Interleukin-6 Receptor With Interleukin-6 in Human Hematopoiesis
Q53587549Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Q54288880Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients.
Q54365048Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation.
Q45421534Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients.
Q73390744Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF)
Q33384788Role of platelet volume indices in the differential diagnosis of thrombocytopenia: a simple and inexpensive method
Q36308971Role of stem cell transplantation in myeloma
Q89103079Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia
Q33394562Romiplostin may revert the thrombocytopenia in graft-versus-host disease
Q48168851Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosis
Q55057300Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics.
Q91053548Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009-2015
Q54491157SDF-1/CXCR4 signal is involved in decreased expression of p57kip2 in de novo MDS patients.
Q33442438Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis
Q40117299Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis
Q86051320Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis
Q87875744Sclerosing Mediastinitis Masquerading As A Lymphoma
Q43083990Screening for glucose-6-phosphate dehydrogenase deficiency in blood donors
Q50503683Screening of blood donors for erythrocyte alloantibodies.
Q88750327Screening of prognostic risk microRNAs for acute myeloid leukemia
Q51258001Screening of renal dysfunction among Burkitt lymphoma survivors by novel markers.
Q50794138Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution.
Q36069481Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia
Q46364019Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution.
Q87433768Secondary erythrocytosis
Q40217390Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction
Q44670178Selective apoptosis of multiple myeloma cells in primary samples induced by arsenic trioxide
Q64984214Sensorineural hearing loss in children with sickle cell anemia and its association with endothelial dysfunction.
Q54246693Sequence typing of human adenoviruses isolated from Polish patients subjected to allogeneic hematopoietic stem cell transplantation - a single center experience.
Q74000732Sequential Variations in the Content of Bone Marrow Colony-forming Cells in Individual Patients with Aplastic Anemia Before and After Immunosuppressive Therapy; Hematopoiesis
Q84917040Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies
Q87912683Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study
Q74000779Serum Ferritin is a Reliable, Non-invasive Test for Iron Status in Pregnancy: Comparison of Ferritin with Other Iron Status Markers in a Longitudinal Study on Healthy Pregnant Women; Erythropoiesis
Q87879587Serum Levels of Soluble CD 30 and Their Relationship to Tumour Burden and Prognosis in Patients with Hodgkin's Disease
Q89547204Serum chitotriosidase: a circulating biomarker in polycythemia vera
Q53565332Serum elastase and antithrombin-3 levels after umbilical cord blood transplantation or bone marrow transplantation.
Q48165701Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia.
Q81409260Serum leptin level in acute myeloid leukemia patients
Q83063416Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia
Q81243470Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases
Q92484155Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens
Q84299415Serum prohepcidin in pulmonary tuberculosis
Q33367291Severe gestational (incidental) thrombocytopenia: to treat or not to treat
Q47693182Sex chromosome changes in leukemia: cytogenetics and molecular aspects.
Q47684184Short Communication: Expression of Apoptosis Regulating Factors on T Lymphocytes in Multiple Myeloma Patients.
Q87897569Short Report: Translation of Analysis Results between Serum Ferritin Assays, Ferritin RIA Amersham™ and Abbott AxSYM™ Ferritin
Q33385546Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report
Q80677037Should we test TPMT enzyme levels before starting azathioprine?
Q57624600Sickle cell disease
Q40109904Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals
Q46214476Sickle cell disease in a carrier with pyruvate kinase deficiency.
Q42790711Sickle cell disease serum induces NADPH enzyme subunit expression and oxidant production in leukocytes
Q81271191Sickle cell disease: a multigenic perspective of a single gene disorder
Q38847369Sickle cell/β-thalassemia: Comparison of Sβ0 and Sβ+ Brazilian patients followed at a single institution
Q33369160Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura
Q38896241Signal Transduction by the Philadelphia Chromosome-encoded BCR/ABL Oncoproteins: Therapeutic Implications for Chronic Myeloid Leukemia and Philadelphia-positive Acute Lymphoblastic Leukemia
Q54150547Signet-ring Cell Lymphoma-a Case Report.
Q46399776Silent angiodysplasia and occult haemobilia as rare but treatable causes of refractory iron deficiency--two case reports
Q87911400Similarity Between Multiple Sclerosis and Idiopathic Central Nervous System Dysfunction After Bone Marrow Transplantation
Q74597221Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation
Q40555233Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis
Q37234366Simulation of various randomization strategies for a clinical trial in sickle cell disease
Q43083993Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia
Q33405314Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab
Q39573956Simultaneous targeting of P-gp and XIAP with siRNAs increases sensitivity of P-gp overexpressing CML cells to imatinib.
Q28199044Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Q33396252Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults
Q33433836Skin Necrosis Associated With Heparin-Induced Thrombocytopenia and Thrombosis
Q74816942Skin infiltration with chronic lymphocytic leukemia is consistent with a good prognosis
Q81018119Skin rash in a patient who underwent allogeneic bone marrow transplatation for AML
Q36799626Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature
Q38900001Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease
Q99602656Small PNH clones detected by fluorescent aerolysin predict a faster response to immunosuppressive therapy in patients with severe aplastic anaemia
Q43235022Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results
Q35670989Solitary plasmacytoma in the setting of Langerhans cell histiocytosis
Q46231985Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease
Q42599546Soluble Receptors for Tumor Necrosis Factor and Neopterin as Parameters of Cell-Mediated Immune Activation
Q46877293Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Q43838003Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics
Q92484186Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis
Q35552528Somatic hypermutation patterns in germinal center B cell malignancies
Q47683086Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective
Q74000827Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective; Subject Heading
Q50645853Spectrum of diseases diagnosed on bone marrow examination of 285 infants in a single tertiary care center.
Q37212363Spectrum of pure red cell aplasia in adult population of north-west India.
Q33369401Splenectomy in haematology--a 5-year single centre experience
Q38882070Splenic enlargement in adults with homozygous sickle cell disease: the Jamaican experience
Q38541600Splenic infarction associated with sickle cell trait at low altitude
Q82292954Splenic marginal zone lymphoma--a clinicopathological study in a series of 16 patients
Q48331134Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
Q79358893Splenic mass in a 42-year-old woman
Q36269955Split-signal FISH for detection of chromosome aberrations.
Q103838492Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state
Q35126985Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature
Q46754921Stability of activated partial thromboplastin time (APTT) test under different storage conditions
Q57770593Stage I-III Hodgkin's Disease: Outcome and Pattern of Failure Following Treatment with Radiation Therapy and Chemotherapy in a Modern Era
Q62032120Statement of Retraction
Q81344310Statement of duplicate publication
Q54292567Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India.
Q34278296Stem Cell Transplantation for Chronic Lymphocytic Leukaemia: Is this the Way Forward in the New Millennium?; Malignancy; Current Clinical Practice
Q56777940Stem cell plasticity
Q44244814Stem cell transplantation for multiple myeloma: current and future status
Q36269933Stem cell transplantation in multiple myeloma
Q47679424Stigma and illness uncertainty: adding to the burden of sickle cell disease.
Q47624338Stromal Cell Types: Characterization and Function In Situ and In Vitro
Q89763229Students' knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo
Q33425566Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library
Q84289215Study of clinical and aetiological profile of 100 patients of pancytopenia at a tertiary care centre in India
Q53540488Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia.
Q40174632Sub classification and clinico-hematological correlation of 40 cases of acute erythroleukemia - can proerythroblast/myeloblast and proerythroblast/total erythroid cell ratios help subclassify?
Q47684209Successful Cytoreduction with CAG (cytarabine, Aclarubicin and G-CSF) Therapy in Refractory Acute Myelogenous Leukemia before Allogeneic Stem Cell Transplantation
Q44506531Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors
Q74627662Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia
Q53568893Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome.
Q44769904Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin
Q82292962Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis
Q74816934Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report
Q36194555Survey of hematological aspects of Gaucher disease
Q87911398Survival from Acute MyeloidLeukaemia in Patients Over 55 Years of Age in Northern Ireland: A Discrete Population
Q87879597Susceptibility to Infection Due to Diminished Interferon-α-Producing Capacity in Patients with Refractory Anemia with Excess of Blasts or Refractory Anemia with Excess of Blasts in Transformation
Q36270166Symptom management in hematological patients
Q48070699Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma
Q89012572Synchronous dual hematological malignancies: new or underreported entity?
Q44545373Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors
Q88134514Synergistic effects of rmhTRAIL and 17-AAG on the proliferation and apoptosis of multiple myeloma cells
Q35080315T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
Q36687986T-large granular lymphocyte leukemia: current molecular concepts.
Q92015401T-lymphocyte subsets and Th1/Th2 cytokines in convalescent patients with Epstein-Barr virus-associated aplastic anemia
Q50599354TCR zeta chain expression in T cells from patients with CML.
Q50002024TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Q88247979THE 36TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF HEMATOLOGY 2016 Glasgow 18(th) -21(st) April 2016
Q104141315Tacrolimus is effective in relapsed/refractory autoimmune cytopenias: results of a single-center retrospective study
Q44772522Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia
Q42717692Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML).
Q92479972Targeted next-generation sequencing identified a novel ANK1 mutation associated with hereditary spherocytosis in a Chinese family
Q36194545Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis
Q54515803Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy.
Q53172892Targeted therapy of multiple myeloma.
Q90165293Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia
Q64047404Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma
Q39305147TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Q46200205Technetium-99m Sestamibi Scanning Reflects Marrow Activity in a β-Thalassemia Patient Treated with an Allogeneic Bone Marrow Transplant
Q87911045Technical Report: Triple-Colour Staining Flow Cytometry for Co-Distribution of Thrombospondin Receptor (CD36), Ribonucleic Acid (RNA) and Fetal Haemoglobin (HbF) in Sickle Red Blood Cells
Q54609545Telomeres, Telomerase and Leukaemia.
Q35668682Th1/Th2 cells in patients with multiple myeloma
Q83903723Thalassemia
Q33370469Thalassemia major-- on the verge of bleeding or thrombosis?
Q40531242Thalidomide effects in the post-transplantation setting in patients with multiple myeloma
Q48110343Thalidomide has a significant effect in patients with thalassemia intermedia.
Q73634892Thalidomide in the management of multiple myeloma
Q45204109The 5q- syndrome
Q87912913The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease
Q74000812The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; Malignancy
Q87879063The Diagnosis and Treatment of Iron Deficiency Anaemia
Q87878291The Effect of Hemodialysis on the Expression of Platelet Glycoproteins Ib, IIb/IIIa and P-Selectin
Q38984259The Egyptian experience with oral iron chelators
Q87903575The Haematologist and the Infective Complications of HIV Infection
Q87896936The Hematopoietic Microenvironment
Q47622134The Hematopoietic Microenvironment.
Q74000430The Hematopoietic Microenvironment: Heterogeneity of Bone Marrow Stromal Cells: Growth Properties and Cytokine Production by CD34+ and CD34- Stromal Sub-Sets
Q74000622The Hematopoietic Microenvironment: Matrix Metalloproteinases in the Hematopoietic Microenvironment
Q52134108The Hematopoietic Microenvironment: Osteoblasts and The Hematopoietic Microenvironment.
Q74000504The Hematopoietic Microenvironment: Phenotypic and Functional Characterization of Human Marrow Vascular Stromal Cells
Q74000423The Hematopoietic Microenvironment: Phylogeny and Ontogeny of the Hematopoietic Microenvironment
Q74000497The Hematopoietic Microenvironment: Stromal Cell Types: Characterization and Function In Situ and In Vitro
Q74000520The Hematopoietic Microenvironment: Stromal Extracellular Matrix Components As Growth Regulators For Human Hematopoietic Progenitors
Q74000584The Hematopoietic Microenvironment: The Osteogenic Compartment of Bone Marrow: Cell Biology and Clinical Application
Q40008183The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' population
Q87879580The Management of Essential Thrombocythaemia
Q87879349The Management of Polycythaemia Vera
Q81271216The Mexican approach to conduct allogeneic stem cell transplantation: braking dogmata and facing the Matthew effect
Q38897747The Natural History of Hepatitis C Virus Infection in Hemophiliacs
Q87912388The Number of Nucleoli and Main Nucleolar Types in Lymphoblasts of Children Suffering from Acute Lymphoid Leukemia
Q87924337The Osteogenic Compartment of Bone Marrow: Cell Biology and Clinical Application
Q38897750The Pathogenetic Role of Apoptosis in Hypercoagulable States
Q87903567The Rationale for not Routinely Purging Autologous Blood Stem Cell Grafts
Q42496148The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis
Q54780723The Relevance of Circulating Interleukin-5 (IL-5) in Lymphoproliferative Disorders.
Q47683876The Retinoblastoma Gene in Myeloid Leukaemias
Q54151129The Role of Allogeneic Transplantation in the Treatment of Multiple Myeloma.
Q46073592The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease
Q46054381The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease; Haemoglobinopathy.
Q38896599The Scope of Viral Vectors for the Transduction of Haemopoietic Cells
Q38896186The Syndrome of Veno-occlusive Disease After Blood or Marrow Transplantation
Q39870874The T-cell receptor Vbeta gene repertoire and clonal expansion from peripheral blood T cells in benzene-exposed workers in China
Q81450840The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen
Q81018099The antiphospholipid syndrome
Q90291773The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia
Q104567091The association between pre-transfusion hemoglobin levels and thalassemia complications
Q34160906The association between the copy-number variations of ZMAT4 and hematological malignancy
Q53793130The association of cytokine genes polymorphisms and susceptibility to aplastic anemia in Egyptian patients.
Q47806850The care of a child with multiple trauma and severe anemia who was a Jehovah's Witness
Q92754913The challenges of handling deferasirox in sickle cell disease patients older than 40 years
Q43485191The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain
Q54213442The clinical characteristics and therapy response of patients with acquired pure red cell aplasia.
Q91035245The clinical outcomes of chronic myeloid leukemia patients harboring alternatively spliced BCR-ABL variants
Q47292792The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia.
Q33403270The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia
Q91964056The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia
Q43014785The clinico-hematological profile of hairy cell leukaemia: a single centre experience
Q45899996The cost of hematopoietic stem cell transplantation in the real world.
Q98285819The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma
Q38747300The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies
Q96612073The diagnostic and prognostic value of MRI in central nervous system involvement of acute myeloid leukemia: a retrospective cohort of 84 patients
Q36415999The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis
Q48832311The effect of automated alerts on preoperative anemia management.
Q45817965The effect of combined therapy with deferoxamine and deferiprone on serum ferritin level of beta-thalassemic patients
Q43014781The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia
Q86084751The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
Q96612070The effect of rat nerve growth factor combined with vitamin B on peripheral neuropathy in multiple myeloma patients
Q51759875The effect of storage on the clinical utility of the immature platelet fraction.
Q46082575The effect of subclinical hypothyroidism on platelet parameters
Q84965334The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients
Q36356141The effects of a data driven maximum surgical blood ordering schedule on preoperative blood ordering practices
Q53589582The effects of iron treatment on viscosity in children with cyanotic congenital heart disease.
Q91252062The effects of storage on platelet function in different blood products
Q102064401The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis
Q53113161The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
Q55052407The evaluation of the periodontium in patients with leukemia using thermographic imaging.
Q35173179The evolving role of monoclonal antibodies and dendritic cell therapy in hematologic malignancies
Q37639505The expanding spectrum of thalassemia intermedia.
Q84429869The expression of LMO2 protein in acute B-cell and myeloid leukemia
Q54365040The expression pattern of CD3 chain genes in fetal/maternal interface.
Q33385552The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura
Q82653376The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience
Q36415991The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights
Q36069469The haematology of indigenous Australians
Q92378390The imbalance between regulatory memory B cells reveals possible pathogenesis involvement in pediatric immune thrombocytopenia
Q50216333The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients.
Q46979642The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura
Q83903731The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL)
Q46160587The impact of trisomy 12, retinoblastoma gene and P53 in prognosis of B-cell chronic lymphocytic leukemia
Q81514979The impact on resources of prevalence and nature of skin problems in a modern intensive haemato-oncology practice
Q36270014The importance of the protein C system in the pathogenesis of venous thrombosis
Q90340861The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis
Q46952184The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis
Q46364014The interaction between taxoids and serine/threonine protein phosphatase activities during taxan-induced apoptosis of HL 60 leukemic cells.
Q53142140The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors.
Q38525519The method of in vivo evaluation of hemostasis: Spatial thrombodynamics
Q33368674The molecular basis of congenital thrombocytopenias: insights into megakaryopoiesis
Q36270139The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment
Q47593550The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study
Q39851549The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia
Q80376729The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation
Q36194570The platelet-function analyzer (PFA-100) for evaluating primary hemostasis
Q38003020The plurality of payers' perspectives on hematopoietic stem cell transplantation
Q50646785The possible role of reticulocytes in sickle cell disease associated thromboembolism.
Q47556784The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients.
Q48208737The potential association of tumor necrosis factor-βeta (252 G/A) cytokine gene polymorphism with immune thrombocytopenic purpura among Egyptian children
Q103838491The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis
Q50235213The preparation, characterization, and application of environment-friendly monoclonal antibodies for human blood cell.
Q39288602The prevalence of G6PD deficiency in blood transfusion recipients.
Q40800776The prevalence of alpha-thalassemia amongst Tai and Mon-Khmer ethnic groups residing in northern Thailand: A population-based study
Q85493878The prevalence of the platelet glycoprotein VI polymorphisms in patients with sticky platelet syndrome and ischemic stroke
Q104513289The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis
Q52669788The prognostic impact of long noncoding RNA HOTAIR in leukemia and lymphoma: a meta-analysis.
Q49114034The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma.
Q51969115The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia.
Q45036513The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes
Q35552523The proteasome: a novel therapeutic target in haematopoietic malignancy
Q81409270The proto-oncogene expression varies over the course of chronic myeloid leukemia
Q38997520The questioning for routine monthly monitoring of proteinuria in patients with β-thalassemia on deferasirox chelation
Q44944864The red cell distribution width (RDW): value and role in preterm, IUGR (intrauterine growth restricted), full-term infants.
Q35605124The regulatory mechanism of IL-6-dependent proliferation of human myeloma cells
Q89176459The relationship between gene polymorphism of MTRR A66G and lower extremity deep venous thrombosis
Q89733757The relationship between interferon-gamma (INF-γ) single nucleotide polymorphism +874(T/A) and occurrence risk of aplastic anemia: a meta-analysis
Q90463114The research progress of circular RNAs in hematological malignancies
Q33368671The role of ADAMTS13 in the new pathogenesis of TTP.
Q33406725The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia
Q46466632The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients
Q33442321The role of bone marrow microenvironment in platelet production and their implications for the treatment of thrombocytopenic diseases
Q103720489The role of cystatin C as a proteasome inhibitor in multiple myeloma
Q51102870The role of follicular T helper cells in patients with malignant lymphoid disease.
Q38729618The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells
Q38203927The role of notch signaling in bone marrow niche.
Q39116002The role of rs1984112_G at CD36 gene in increasing reticulocyte level among sickle cell disease patients.
Q39197389The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells
Q46575243The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts.
Q89958934The safety of modern intravenous iron infusions in patients with rheumatoid arthritis - a review of the literature
Q114098158The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients
Q38083900The sticky platelet syndrome
Q89492463The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study
Q36269943The treatment of AML: current status and novel approaches
Q38842954The treatment of CML at an environment with limited resources.
Q45925774The tumour necrosis factor as a mediator of vessel inflammation: importance of exposed receptor residues for its neutralization.
Q35668672The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL).
Q93244196The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments
Q53636425The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Q37183517The use of recombinant activated factor VII in platelet-associated bleeding
Q81973595The use of short tandem repeat polymorphisms for monitoring chimerism following bone marrow transplantation: a short report
Q43741190Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18)F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma
Q91128211Therapeutic options for adult patients with previously treated immune thrombocytopenia - a systematic review and network meta-analysis
Q33394558Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center
Q35809447Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment
Q74000688Therapy: Hyperbaric Oxygen as the Only Effective Treatment in Mutilating and Resistant Systemic Vasculitis
Q47838580Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.
Q33375518Thirty-nine cases of pure red cell aplasia: a single center experience from India
Q33369162Thrombocytopenia due to cytomegalovirus infection in an immunocompetent adult
Q33367297Thrombocytopenia in patients with severe acute respiratory syndrome (review).
Q33433930Thrombocytopenia-Platelet Support or Growth Factors?
Q87879809Thrombocytosis in Malignancy: A Paraneoplastic Syndrome?
Q38897787Thromboelastography.
Q48372138Thromboembolism following cesarean section: a retrospective study
Q36761733Thromboembolism in childhood nephrotic syndrome: a rare but serious complication
Q44097268Thromboembolism in patients on thalidomide for myeloma
Q82834997Thrombomodulin and GFC levels in Legg-Calve-Perthes disease
Q81271240Thrombophilia and pregnancy
Q45343630Thrombophilia and varicella zoster in children
Q46396319Thrombophilic DNA Mutations As Independent Risk Factors for Stroke and Avascular Necrosis in Sickle Cell Anemia
Q48484275Thrombophilic gene mutations in children with migraine.
Q33433774Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia.
Q33365357Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia
Q38897684Thrombopoietin Gene Regulation-A Review.
Q50113572Thrombopoietin and its receptor expression in pediatric patients with chronic immune thrombocytopenia.
Q33400774Thrombopoietin: too much or too little
Q54338067Thrombosis and acute leukemia.
Q38003019Thrombosis in multiple myeloma (MM).
Q38003018Thrombosis in myeloproliferative and myelodysplastic syndromes
Q45878587Thrombosis in rare bleeding disorders
Q33400771Thrombosis in stem cell transplantation
Q36415995Thrombotic complications in von Willebrand disease
Q46214484Thrombotic complications of polycythemia vera
Q33374370Thrombotic microangiopathies: an update
Q78639201Thrombus formation with rehydrated, lyophilized platelets
Q92276856Time course of peripheral blood count recovery during induction chemotherapy for childhood acute lymphoblastic leukemia
Q36761725Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia
Q51694454Tissue chimerism analysis after donor lymphocyte infusion: a case of deceptive evidence.
Q47819163Tolerability and safety of the intravenous immunoglobulin octagam(®) 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials.
Q73795173Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome
Q92837370Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia
Q38849609Transforming growth factor 15 increased in severe aplastic anemia patients
Q36270091Transfusion immunomodulation or TRIM: what does it mean clinically?
Q36270080Treatment algorithms in CLL.
Q36308975Treatment of AML in biological subgroups
Q36307574Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review
Q87899106Treatment of Relapsing Ph+ Acute Lymphoblastic Leukemia with Donor Leukocyte Infusion Followed by Quantitative Monitoring of Residual Disease
Q36270070Treatment of T-Cell lymphoma
Q83903705Treatment of acquired aplastic anemia in children
Q39103020Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience
Q50642217Treatment of alpha(0)-thalassemia (--(SEA)/--(SEA)) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes?
Q45952018Treatment of hairy cell leukemia: long-term results in a developing country.
Q36269915Treatment of indolent lymphomas from watch and wait to high dose therapy
Q34875188Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation
Q33374580Treatment of thrombotic microangiopathies with plasma exchange
Q87896669Treatment of von Willebrand Disease
Q36269910Treatment options in early stages of Hodgkin's Lymphoma, high cure rate with lower short and long-term toxicity
Q41636233Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA.
Q42790714Treatment related changes in antifibrinolytic activity in patients with polycythemia vera
Q38980392Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the 'real life' setting: A single center observational study
Q58001055Trisomy 12 and t(14;22)(q32;q11) in a Patient with B-cell Chronic Lymphocytic Leukemia
Q87876094Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and Morphology
Q44146994Troxacitabine activity in extramedullary myeloid leukemia
Q36844906Troxacitabine in acute leukemia
Q36868592Troxacitabine in leukemia
Q80559460Tuberculosis in acute leukemia: a clinico-hematological profile
Q81973603Tumour necrosis factor and its receptor: a basic structural analysis of two counterparts
Q54773736Type J CBFβ/MYH11 Transcript in the M4Eo Subtype of Acute Myeloid Leukemia
Q61913814Ultrastructural analysis of platelets during three phases of pregnancy: A qualitative and quantitative investigation
Q80559465Umbilical cord blood transplantation using non-myeloablative conditioning: the Mexican experience
Q79839452Unbalanced bone turnover in children with beta-thalassemia
Q89626939Understanding of the significance and health implications of asplenia in a cohort of patients with haemaglobinopathy: possible benefits of a spleen registry
Q87879787Understanding the Graft-Versus-Leukaemia Reaction
Q40673251Unexpected Epithelial Membrane Antigen (EMA) and Cytokeratin Expression in a Case of Infantile Acute Monoblastic Leukaemia
Q50489416Unique red cell abnormality in a case of fatal methylene blue induced haemolysis.
Q51801563Unusual extramedullary recurrences and breast relapse despite hepatic GVHD after allografting in Ph+-ALL.
Q54482734Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient.
Q91736161Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment
Q104567046Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238
Q36269919Update on lymphoma management: diffuse large B-cell NHL.
Q35809195Update on the treatment of disseminated intravascular coagulation
Q91971227Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study
Q53864352Upon drug-induced apoptosis expression of prostate-apoptosis-response-gene-4 promotes cleavage of caspase-8, bid and mitochondrial release of cytochrome c.
Q38843959Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma
Q46413575Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia
Q81243508Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance
Q79358883Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion
Q87896118Use of Bisphosphonates in the Treatment of Multiple Myeloma
Q51759871Use of HbA estimation by CE-HPLC for prenatal diagnosis of beta-thalassemia; experience from a tertiary care centre in north India: a brief report.
Q84787075Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy
Q57098520Use of cryoprotectant-depleted allogeneic peripheral blood stem cells for transplantation
Q93050001Use of decitabine for patients with refractory or relapsed acute myeloid leukemia: a systematic review and meta-analysis
Q45988194Use of imatinib mesylate in elderly patients in Northern Ireland: evidence of comparable haematological and molecular responses to younger patients.
Q46374598Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease
Q33370467Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplant
Q46712150Usefulness of red blood cell flags in diagnosing and differentiating thalassemia trait from iron-deficiency anemia.
Q87901917Uses of Column Technology in Blood Transfusion
Q47562573Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis
Q37293519Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy.
Q39078119VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia
Q39337509Valproic acid inhibits proliferation of EB virus-infected natural killer cells
Q38015946Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience
Q48561018Value of speckle tracking echocardiography for detection of clinically silent left ventricular dysfunction in patients with β-thalassemia.
Q87426764Values of mean cell volume and mean sphered cell volume can differentiate hereditary spherocytosis and thalassemia
Q36497387Venous thrombosis associated with pernicious anaemia. A report of two cases and review
Q40387597Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition
Q43785371Viral lymphomas: can antivirals be used to treat cancer?
Q36270026Virtual microscopy: applications to hematology education and training
Q87450132Von Willebrand disease
Q51607495Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis.
Q97541013Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa
Q89980410WT1 overexpression predicted good outcomes in adult B-cell acute lymphoblastic leukemia patients receiving chemotherapy
Q36269963WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias
Q33400766Waldenström macroglobulinemia.
Q43173269Whither the bone marrow transplant?
Q87878289Why Collaboration is Necessary Between Worldwide Bone Marrow Registries
Q92837397Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?
Q83304136Wilms' tumor protein and FLT3-internal tandem duplication expression in patients with de novo acute myeloid leukemia
Q45173841XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients
Q93183696Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experience
Q36194583Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment
Q53301647c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
Q53145261mRNA expression and promoter DNA methylation status of CDKi p21 and p57 genes in ex vivo expanded CD34 (+) cells following co-culture with mesenchymal stromal cells and growth factors.
Q90694242miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1
Q46716752rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Q52934047rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
Q39355494shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells
Q80677012t(14;18)(q32;q21)-bearing pleural MALT lymphoma with IgM paraproteinemia: value of detection of specific cytogenetic abnormalities in the differential diagnosis of MALT lymphoma and lymphoplasmacytic lymphoma
Q79840229t(8;16) AML developed subsequent to breast cancer therapy
Q79441310t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience
Q48269594β(S) globin gene haplotype and the stroke risk among Egyptian children with sickle cell disease

Search more.